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ABSTRACT 
Michael J. Geier:  New Mechanisms for Turnover and Functionalization in the Platinum 
Initiated Cyclization of Polyenes 
(Under the direction of Michel Gagné)  
 
 The replication of nature’s ability to convert acyclic polyenes to polycycles has long 
been the target of synthetic chemists.  Progress has been made through manipulation of both 
substrate and initiator to achieve products of increasing complexity.  While significant 
advances have been made, the abilities of the synthetic chemist pale in comparison to that of 
nature. 
 In an effort to bridge this gap, several areas have been explored.  Current synthetic 
methods for the synthesis of C3-oxygenated polycycles rely upon pre-installation of the 
oxygen functionality.  Development of a catalytic scheme for the generation of several C3-
oxygenated polycycles using molecular oxygen as the oxygen source has been achieved.  
This scheme proceeds through a unique Pt(III) intermediate which undergoes homolytic 
cleavage of the Pt-C bond before interception of the alkyl radical. 
 Application of a (CNC)Pt
2+
 pincer complex to the cyclization of polyene substrates 
has resulted in a remarkably efficient cycloisomerization.  Where phosphine ligated Pt 
complexes have proven remarkably stable toward oxidation, rapid Pt-alkyl 
protodemetallation was observed.  This complex was particularly effective in initiating 
cyclization of the more challenging alkene terminating substrates, forming up to four rings 
and five stereocenters in a single step. 
iv 
 Extension of this cycloisomerization methodology to substrates which proceed 
through secondary carbocations has allowed for a unique opportunity to study the nature of 
polycyclization reactions experimentally.  Through selective substrate demethylation, a 
concerted yet highly asynchronous process was uncovered, revealing a process highly 
dependent on the stability of the A ring. 
 En route to exploration of new methods for oxygenation of the C-3 position, an 
opportunity for the fundamental study of reductive elimination from Pt(IV) complexes arose.  
Under standard conditions, reactions of a Pt(II) organometallic complex with electrophilic 
halonium reagents resulted in stereoretentive reductive elimination.  Addition of the 
appropriate anion to these reactions resulted in a switch in the mechanism of reductive 
elimination, forming the invertive halogenation products. 
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CHAPTER 1:  INTRODUCTION
Enzyme Catalyzed Terpene Cyclization 
Nature’s ability to mediate the formation of a variety of complex products is 
unmatched by current synthetic methods.  This remarkable capacity for chemical 
manipulation is perhaps best exemplified in the enzyme catalyzed terpene cyclization 
reactions.
1
  These reactions provide complex polycyclic products with full stereocontrol from 
simple achiral polyene substrates.   
A number of these polycyclic compounds are the products of multiple enzyme 
catalyzed reactions, ultimately derived from the substrate squalene.
2
  In bacteria, squalene is 
converted to hopene by squalene-hopene cyclase, while plants, animals and fungi first 
enantioselectively epoxidize squalene to (3S)-2,3-oxidosqualene with squalene epoxidase and 
molecular oxygen.
1b,1d,e
  Cyclization of 2,3-oxidosqualene leads to products with a 6,6,6,5 
framework and an alcohol moiety at C3and are known as the sterol family of compounds 
which includes lanosterol and cycloartenol (Figure 1.1).
1a,3
  These compounds are the 
precursors to a wide variety of better known natural products including cholesterol and 
testosterone.   
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Figure 1.1:  Enzymatic cyclization of squalene 
The fundamental chemical process that underpins terpene cyclization chemistry is the 
cation-olefin reaction, where transiently generated carbocations
4
 rapidly react with alkenes 
which have been pre-organized within the enzyme to make a C-C bond and regenerate the 
carbocation.  This process, which converts long chain polyenes to predominantly saturated 
polycyclic compounds is thermodynamically favorable due to the conversion of C-C double 
bonds to C-C single bonds, all while converting double bonds to rings.
5
 
The cyclization of squalene to hopene by squalene hopene cyclase represents a 
comparatively simple transformation.  Squalene is held in an all chair conformation within 
the enzyme.  Protonation of the 2,3-alkene from an acidified aspartic acid residue initiates the 
cascade and a series of five cation olefin reactions ensues, to be terminated by an elimination 
of the final exocyclic tertiary carbocation to form the E-ring isopropenyl group (Figure 1.2). 
 3 
 
 
Figure 1.2:  A stepwise illustration of the conversion of squalene to hopene 
 
 The oxidosqualene cyclases are believed to have evolved from the squalene hopene 
cyclase.
1c
  While squalene hopene cyclase is able to accommodate several different 
substrates, the oxidosqualene cyclases are more substrate selective, and possess the ability to 
distinguish between (3S) and (3R)-2,3-oxidosqualene.  In contrast to the all chair 
conformation of squalene enforced by squalene cyclase, 2,3-oxidosqualene cyclase induces a 
chair-boat-chair conformation (Figure 1.3), resulting in significant alteration of the 
framework.
1d
  Cyclization of 2,3-oxidosqualene is initiated by protonation of the epoxide.  A 
series of cation olefin reactions and skeletal rearrangements generates a tertiary carbocation 
at the junction of rings B and C which eliminates to the tetrasubstituted alkene product.
1d
 
 
Figure 1.3:  Comparison of conformation in squalene and oxidosqualene. 
 4 
 
The concerted nature of the enzyme mediated polycyclization of triterpene substrates 
has long been debated,
1d
 with several studies suggesting stepwise processes involving 
formation of discrete carbocationic intermediates
6
 while others have suggested a more 
concerted process with several transformations occurring without the formation of 
intermediates.
7
 
 Much of the theoretical work in this area has benefited from the report of Schulz in 
which an X-ray structure of 2-azasqualene was obtained within the hopene cyclase enzyme.
8
  
The conformation in which the squalene derivative was held within the enzyme provided a 
starting point for many of the calculations used to assess the nature of the cyclization. 
 Several computational investigations by Hess on a variety of truncated squalene 
models revealed the concerted but highly asynchronous formation of the A,B and C rings of 
hopene.  It was shown that full closure of the A ring is observed prior to significant 
engagement of the B and C rings.
9
  While the A and B rings form via a cation-olefin reaction 
that generates the most favorable 3˚ carbocations (6-endo ring closures), the C-ring closes by 
a kinetically controlled 5-exo cyclization to generate a 3˚ carbocation rather than the 2˚ 
carbocation that a 6-endo regiochemistry would have required.  Such a process requires little 
susbtrate reorganization relative to the structure obtained by Schulz.
7b,9
  This exocyclic 
carbocation is then believed to undergo concerted C-ring expansion and D ring formation, a 
process that is then repeated for D ring expansion and E ring formation (Figure 1.4).
10
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Figure 1.4:  Intermediates in squalene cyclization 
 The enzymatic cyclization of oxidosqualene to lanosterol is believed to proceed in a 
similar fashion with concerted formation of the A, B and C rings, proceeding by an 
alternative chair-boat-chair conformation (Figure 1.5).
11
  Recent calculations have shown the 
process to be highly asynchronous, with nearly full closure of the A ring prior to any 
significant interaction between the developing carbocation and the sequence that forms the B 
and C rings.
12
  The formation of these three rings has been shown to release 39 kcal/mol, 
slightly less than formation of the A-B and C rings of hopene (48 kcal/mol), a difference 
which has been attributed to the boat conformation of the B ring in lanosterol. 
 6 
 
 
Figure 1.5:  Intermediates in the formation of lanosterol 
The cyclizations of squalene and oxidosqualene  have been calculated to proceed 
strictly through tertiary carbocation intermediates.
1d
  These calculations have shown that the 
intermediacy of high energy secondary carbocations along the reaction path can be avoided 
by allowing several transformations to occur in concert.  In both cyclizations, initial 
formation of the 6-6-5 skeleton occurs, and is followed by concerted C ring expansion and D 
ring formation.  These two transformations occur in tandem to avoid what would otherwise 
be a secondary carbocation formed in a step-wise process following C ring expansion (Figure 
1.6).
7a
 
 7 
 
 
Figure 1.6:  Concerted C ring expansion and D ring formation 
 Nature’s aversion to the formation of secondary carbocationic intermediates is not 
ubiquitous.  Several calculations have revealed that secondary carbocations can exist as 
intermediates,
13
 their structures, however, are highly stabilized within the enzyme.
14
  The 
enzymatic stabilization of these secondary carbocations has allowed for anti-Markovnikov 
selectivity to be observed in the biosynthesis of several several natural products.  The 
humulyl cation has been shown by computational methods to be an intermediate in the 
conversion of farnesyl diphosphate to pentalenene (Figure 1.7).
13a
 
 
Figure 1.7:  Humulyl cation intermediate in the formation of pentalenene 
Biomimetic Approaches to Cascade Cyclization  
The unique selectivity displayed by cyclase enzymes has prompted a variety of 
biomimetic approaches to the construction of similar polycyclic frameworks.
1c,15
  These 
methods are generally initiated solely from the alkene or epoxide terminus and suffer from a 
lack of pre-organization of substrate found within the cyclase enzymes.  This limitation often 
 8 
 
necessitates nucleophilic terminating groups and can result in incomplete cyclization and a 
lack of selectivity.   
 
Figure 1.8:  Stork-Eschenmoser postulate 
 Vital to synthetic approaches to replicate these reactions is the Stork-Eschenmoser 
postulate.  Stork and Eschenmoser postulated a relationship between the alkene geometry of 
the acyclic substrate and the geometry of the ring junction in systems related to terpene 
cyclization.  The hypothesis states that a cis ring junction is formed from the cyclization of Z 
alkenes, while a trans ring junction is formed by cyclization of E alkenes (Figure 1.8).
1c,16
  
This hypothesis allows for stereochemical control of ring junctions based upon the alkene 
geometry of the starting material, and explicitly requires some degree of concertedness in the 
cyclizations. 
A variety of approaches has been devised to synthesize bio-like polycyclic 
frameworks.  Many of these methods rely upon Brønsted or Lewis acids to mimic enzymatic 
substrate protonation, while some more recent approaches have turned to electrophilic 
halonium sources and transition metal catalysis to initiate cyclization.
1c
 
W.S. Johnson was a major contributor to the field of biomimetic cyclization.
17
  His 
approaches generally relied upon carbocation formation by reaction with Brønsted or Lewis 
 9 
 
acids to initiate the cascade.  Early work began with the generation of simple mono and 
bicyclic products in formic acid solution,
18
 confirming the Stork-Eschenmoser postulate.  
Much later, he would become the first to report a non-enzymatic pentacyclization reaction 
toward the total synthesis of sophoradiol (Figure 1.9).
19
  Johnson’s contributions to 
selectivity in polyene cyclizations have also been remarkable.  In his total synthesis of 11α-
hydroxyprogesterone, he reported that the inclusion of a chiral centre in the polyene substrate 
led to diastereoselectivity in the cyclized product (Figure 1.10).
20
  His later use of chiral 
acetal opening to initiate cyclization resulted in a remarkably selective tetracyclization, 
making use of a cation stabilizing fluorine atom to assist in the cyclization (Figure 1.11).
21
 
 
Figure 1.9:  Johnson’s pentacyclization reaction 
 
Figure 1.10:  Johnson’s synthesis of 11α-hydroxyprogesterone 
 10 
 
 
Figure 1.11:  Initiation by chiral acetal opening 
More recent work from Yamamoto has made use of chiral Brønsted Lewis Acids 
which were able to initiate an enantioselective cascade cyclization.   These initiators were 
able to deliver a proton in an enantioselective fashion as a result of the enhanced acidity of 
the BINOL from complexation of the Lewis acidic tin tetrachloride (Figure 1.12).
22
  While 
diastereoselectivities were high, enantioselectivites were moderate.  These reactions also 
suffered from the requirement of an excess of chiral initiator, nucleophilic terminating 
groups, and were plagued by premature termination of the cascade in the case of aryl 
terminating groups, requiring additional steps and reagents to achieve full cyclization. 
Figure 1.12:  Yamamoto’s chiral Brønsted Lewis Acid cyclization 
 E.J. Corey has made a number of contributions to the field of polycyclizations over 
the years, including the total synthesis of scalarenedial.
23
  A more recent report disclosed an 
improved variant of Yamamoto’s chiral Brønsted Lewis Acids.  Use of the larger and more 
Lewis acidic antimony in place of tin, along with the more Brønsted acidic dichloro-BINOL 
 11 
 
derivative allowed for a more active and enantioselective cyclization initiator when 
compared to that of Yamamoto, reporting enantiomeric excesses of up to 92% (Figure 
1.13).
24
  More recently, this approach has been extended to the selective activation of internal 
olefins for predictably controlled cyclizations.  This method was applied to these substrates 
en route to the synthesis of dehydroabietic acid (Figure 1.14) and 4-epipodocarpic acid 
(Figure 1.15).
25
 
 
Figure 1.13:  Corey’s chiral Brønsted Lews acid cyclization 
 
Figure 1.14:  Corey’s synthesis of dehydroabietic acid 
 
Figure 1.15:  Corey’s synthesis of 4-epipodocarpic acid 
 12 
 
  Notably, Ishihara has disclosed an enantioselective halocyclization of polyprenoids 
by delivering I
+
 or Br
+
 from a chiral phosphoramidite to form the C3-halogenated product 
with high enantioselectivity.
26
  Enantiomeric excesses of up 99% were reported with 
moderate yields.  These reactions generated unique C3-functionalized products, however, 
they too were plagued by premature termination of the cyclization, requiring additional steps 
to form polycyclic products (Figure 1.16).  More recently, a catalytic variant was reported in 
which the stoichiometric chiral phosporamidite was replaced with a catalytic amount of a 
phosphate-urea catalyst, unfortunately, this catalytic variant was unable to provide the same 
enantioselectivity, resulting in only a 2% ee.
27
 
 
Figure 1.16:  Halonium induced polycyclization 
Carreira has reported a highly enantioselective cyclization in which an allylic alcohol 
moiety can be activated by the combination of a Lewis acid and a chiral iridium catalyst with 
both aryl and heteroaryl terminating groups being tolerated.
28
  Yields of up to 93% and 
enantiomeric excesses of >99.5% were reported in several cases.  This system was effective 
at initiating bicyclization reactions, however, tricyclization reactions resulted in a 
combination of bi and tricyclized products.  This system has recently been applied in the total 
synthesis of (+)-Asperolide C (Figure 1.17).
29
  Toste has also reported an enantioselective 
polycyclization reaction catalyzed by gold.  Activation of a terminal alkyne initiates the 
cascade while both aryl and heteroatom based nucleophiles were tolerated, producing yields 
and ee’s in the 90’s (Figure 1.18).30 
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Figure 1.17:  Carreira’s total synthesis of asperolide C 
 
 
Figure 1.18:  Toste’s gold catalyzed polycyclization 
A subset of the polyolefin cascade cyclization reactions are those that result in C3-
oxygenated products, similar to those derived from 2,3-oxidosqualene.  This includes the 
sterol family of natural products such as lanosterol and cholesterol as well as the steroid 
family which includes testosterone.  Synthetically, these products have been formed 
exclusively by pre-installation of the oxygen at the C3-position in the polyene substrate, 
often in the form of an epoxide where cyclization can be initiated by epoxide opening (Figure 
1.19). 
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Figure 1.19:  Products derived from 2,3-oxidosqualene 
Much of the early work in this subset of products was performed by Van Tamelen.
31
  
Biomimetic reactions on oxidosqualene-like substrates revealed remarkable rearrangements, 
indicating that much of the skeletal changes observed in nature are in fact not enzyme 
dependent, suggesting the enzyme functions solely to protect the substrate from premature 
termination during rearrangement.
32
  Attempted cyclization of oxidosqualene with SnCl4 
produced several partially cyclized products, among them, a tricyclic product, the result of 
formation of the 5-membered C-ring without subsequent ring expansion and cyclization.  
Termination occurred with a hydride and methyl shift, similar to rearrangements observed in 
nature (Figure 1.20). 
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Figure 1.20:  Biomimetic cyclization of 2,3-oxidosqualene 
 Formation of the desired 6,6,6,5 sterol skeleton in biomimetic reactions has proved 
challenging due to the preferential formation of 5-membered C-rings arising from 5-exo 
Markovnikov ring closure to form the more favorable tertiary carbocation.
33
  This problem 
was overcome by design of an alkyne terminating substrate by van Tamelen in which methyl 
group placement allowed for Lewis acid initiated tetracyclization, forming the sterol 
allopregnanolone with the desired 6,6,6,5 framework (Figure 1.21).
34
 
 
Figure 1.21:  van Tamelen’s synthesis of allopregnolone 
 
Figure 1.22:  Corey’s Al mediated bicyclization 
E.J. Corey has utilized epoxide opening to initiate a variety of cascade cyclization 
reactions.  Early work reported the synthesis of simple bicyclic compounds promoted by 
Lewis acidic aluminum reagents (Figure 1.22).
35
  Application of chiral epoxide starting 
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materials has allowed for the stereocontrolled total synthesis of a remarkable number of C3 
oxygenated natural products including β-amyrin,36 oleanolic acid,36 erythodiol,36 lanosterol,37 
dammarenediol,
38
 serratenediol,
39
 onocerin
40
 and germanicol.
41
  Recent work has involved 
the indium catalyzed cyclization of a series of chiral propargylic alcohols and silyl ethers to 
form polycylic structures in good yield and enantioselectivity.  In these cases, activation was 
achieved by coordination of the indium catalyst to a terminal alkyne, while enantiomeric 
excesses in the 90’s resulted from pre-installation of the chiral propargyl alcohol or silyl 
ether (Figure 1.23).
42
  
 
Figure 1.23:  Cyclization of propargylic alcohol substrate 
Biomimetic Cyclization of Polyenes 
A second, much less explored area of the biomimetic cascade cyclization reactions 
are those that utilize strictly polyene containing substrates.  In contrast to those methods 
which benefit from the enhanced nucleophilicity of heteroatom terminating substrates, or 
those that are aided by cation-pi stabilization in the case of arene terminating substrates, 
alkene terminating groups provide a significantly more challenging target.  Alkene 
terminating groups suffer from a lack of nucleophilicity, the required formation of discrete 
carbocations, as well as the loss of H-bond assistance in heteroatom terminating cyclizations, 
making these substrates much slower to cyclize and prone to incomplete or unselective 
cyclization. 
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Early work in the cyclization of polyene substrates employed mercury salts as 
initiators.  These proved effective at activating alkenes, however they suffered from a lack of 
selectivity, as mercury is unselective in its alkene preference.
43
  These methods also required 
a stoichiometric amount of mercury.  More recently, Nishizawa has reported the cyclization 
of a number of substrates including several alkene terminating substrates.  These substrates 
resulted in several different products, including those arising from incomplete cyclization 
(Figure 1.24); stoichiometric mercury is still required.
44
 
 
Figure 1.24:  Mercury initiated cyclization 
More recent work from the Dunach group has focused on the use of Bi(OTf)3 to 
promote cyclization of polyene substrates.  While Bi(OTf)3 was added as the catalyst, it has 
been proposed that a Lewis acid assisted Brønsted acid type of activation may be responsible 
for the activation, further supported by the ability of triflic acid to promote reactivity.  
Reactions proceeded rapidly, but required elevated temperatures (100˚C) and often provide 
the products as a mixture of diastereomers (Figure 1.25).
45
  In several cases, Wagner 
Meerwein rearrangements were observed.  These carbocation rearrangements can involve  
1,2 migration of a hydride, alkyl or aryl group between neighboring carbons.
46
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Figure 1.25:  Bi(OTf)3 catalyzed bicyclization and rearrangement 
Computation and further experimental studies allowed for the identification of several 
possible intermediates.  Lowering of the temperature from 100˚C to 0˚C allowed for 
formation of two previously unobserved products.  While the Wagner-Meerwein rearranged 
product remained the predominant species at room temperature, a product arising from 
elimination from the initially formed tertiary cabocation as well as a mixture of 
monocyclized products appeared in the reaction mixture (Figure 1.26).  Subjecting these 
products to initial cyclization conditions resulted in formation of the Wagner-Meerwein 
rearranged product.
47
 
 
Figure 1.26:  Formation of multiple products in Bi(OTf)3 catalyzed cylization 
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Secondary Carbocations in Biomimetic Cyclization Reactions 
The synthetic viability of secondary carbocations in catalytic biomimetic cyclization 
reactions has remained relatively unexplored.  Substrates currently employed in these 
reactions have been carefully crafted, controlling ring size and termination geometry by 
strategic positioning of methyl groups within the substrate.  This approach has allowed for 
predictable cyclization reactions, however, it has left an important area of biomimetic 
cyclization reactions relatively untouched. 
The majority of recent efforts to study the involvement of secondary carbocations in 
such cyclizations have been calculations on the enzyme mediated transformations.
14a
  Early 
experimental work from W.S. Johnson has reported several reactions containing secondary 
alkenes,
15b
 while some of his later work has detailed the stabilization of secondary 
carbocations in polyene cyclization reactions.
48
 
Johnson and others have reported several different approaches to initiate polyene 
cyclizations under substrate control.  The addition of a stoichiometric amount of stannic 
chloride to induce acetal opening has proven to be effective for the tricyclization of 
substrates containing secondary alkenes.
49
  Remarkably, this method was also effective for 
inducing tricyclization of a substrate containing two disubstituted alkenes, albeit in lower 
yield and longer reactions times (Figure 1.27).
50
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Figure 1.27:  Cyclization of secondary alkene containing substrates 
 Extension of this protocol to tetracyclization reactions also proved effective, with 
stannic chloride in pentane furnishing the tetracyclic product, setting 7 stereocenters, 
providing only 2 of a possible 64 stereoisomers (Figure 1.28).  
 
Figure 1.28:  Tetracyclization of secondary alkene containing substrate 
The generation of allylic carbocations through several means has also been effective 
in initiating cyclizations that proceed through disubstituted alkenes.  Formation of 
cyclohexenyl,
51
 cyclopentenyl
52
 and tetramethylallylic
53
 cations have been used to induce 
cyclization.  Particularly noteworthy are several examples in which direct comparisons 
between secondary and tertiatry carbocations can be drawn.  Cyclization of vinyl terminating 
and isopropenyl terminating substrates were compared, noting a larger proportion of 
tetracyclized products arising from the isopropenyl terminating substrates, likely due to its 
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enhanced nucleophilicity arising from the stability of the terminal carbocation (Figure 
1.29).
54
 
 
Figure 1.29:  Vinyl and isopropenyl terminating substrates 
 A second example once again draws comparison between vinyl and isopropenyl 
terminating groups.  In the case of the vinyl terminating substrate, a cis ring junction was 
observed in the tetracyclized product.  This unexpected outcome was proposed to arise from 
an initial tricyclization and elimination from the tertiary carbocation.  Protonation of this 
alkene and D ring formation led to a cis ring junction in this stepwise process.  Meanwhile, 
cyclization of the isopropenyl terminating substrate provided the anticipated trans ring 
junctions in the tetracyclized product, indicating a more concerted tetracyclization, once 
again, attributed to the enhanced nucleophilicity of the terminating group (Figure 1.30).
55
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Figure 1.30:  Step-wise vs. concerted tetracyclization 
 Johnson has also reported the application of fluorine to stabilize secondary 
carbocations that ensue during the course of a cascade cyclization.
56
  This approach has 
enabled the previously mentioned pentacyclization
19
 reaction and the total synthesis of 
several natural products.
21,57
  The use of fluorine has also overcome the regiospecificity 
problem during biomimetic C-ring formation.  The anti-Markovnikov C-ring closure 
observed in the enzyme mediated cyclization (ie lanosterol, hopene) has been difficult to 
replicate due to the preference for formation of tertiary over secondary carbocations and the 
aversion to C-ring expansion.
32
  This results in 5-exo C-ring closure followed by elimination 
to form tricyclic products.  Strategic positioning of the fluorine atom to stabilize the 
secondary carbocation allowed for the desired 6-membered C-ring (Figure 1.31).
58
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Figure 1.31:  Fluorine stabilization of 6-membered C-ring 
Electrophilic Pt-initiated Cyclization of Polyenes 
 The use of transition metals to activate unsaturation has long been exploited in 
catalysis.  Coordination of an alkene to a metal centre generates an electrophilic carbon 
centre, prone to nucleophilic attack (Figure 1.32).  In the case of polyunsatured compounds, 
Pt and Pd will preferentially coordinate the least substituted alkene, allowing for selective 
activation.
59
 
 
Figure 1.32:  Metal activation of alkenes 
 This unique tendency of Pd and Pt has been used in the Gagné lab for the cyclization 
of polyene substrates by selective placement of a monosubstituted alkene at the terminus of 
the polyene.  This assures that the catalyst will initiate at the desired position and start the 
cation-olefin cascade at the position favored by enzymes.  Initial studies employing a Pd 
catalyst and an oxidant allowed for catalytic cyclization of polyene substrates with 
heteroatom terminating groups.  Initiation at the monosubstituted alkene led to a polycyclic 
organopalladium species which underwent rapid and unselective β-hydride elimination to 
form several alkene isomers of the products (Figure 1.33).
60
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Figure 1.33:  Palladium catalyzed cyclization 
 A more selective variant of these cyclization reactions employed tridentate ligands on 
both Pd and Pt initiators.  The tridentate ligand creates a coordinatively saturated 
organometallic species upon cyclization, which prevented β-hydride elimination, resulting in 
a series of remarkably stable Pt-alkyl compounds.  As a result of the bulk of the group 10 
metal initiators, these reactions provided excellent diastereoselectivity due to the metal’s 
preference for equatorial disposition (Figure 1.34).
61
 
 
Figure 1.34:  Platinum pincer mediated cyclization 
Application of the (triphos)Pt catalyst to 1,6 and 1,7 diene systems produced a 
catalytic cycloisomerization reaction that initiates with a cation-olefin reaction but turns over 
through rearrangement that forms bicyclopropane products.
62
  Deconstruction of the 
tridentate triphos ligand to a combination of a chiral bidentate and a monodentate ligand 
allowed for easy access to chiral catalysts.  This ligand alteration allowed for enantioselective 
cycloisomerization reactions
63
 (Figure 1.35) as well as a stoichiometric, enantioselective 
polyene cyclization.
64
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Figure 1.35:  Formation of enantiomerically enriched bicyclopropanes 
The cyclization of polyenes with tridentate and deconstructed tridentate phosphine 
ligands was effective in stoichiometric reactions, forming stable Pt organometallics, 
however, these complexes proved remarkably stable toward acid, undergoing protonolysis 
only under strongly acidic conditions.  The triphos ligands proved significantly more 
vulnerable to protodemetallation than their P2P counterparts, an observation rationalized by 
the relief of torsional strain created by the tridentate ligand.
65
  While protonolysis was 
accelerated by increasing the electron density on the triphos ligand, this significantly shifted 
the equilibrium constant toward the uncyclized starting material.
66
 
While tridentate phosphine ligands made for effective initiators, their stability to β-
hydride elimination prevented catalytic turnover.  This situation stimulated development of 
several new turnover mechanisms.  In lieu of the previously used tridentate ligands, Pt 
catalysts with bidentate phosphine ligands provide Pt-R intermediates with a vacant 
coordination site.  Activation and cyclization thus leads to an organometallic species which 
was prone to β-hydride elimination.  This led to a 2,3-unsaturated polycyclic product and a 
Pt-hydride species which could be re-activated through hydride abstraction to turn over the 
catalytic cycle (Figure 1.36).
67
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Figure 1.36:  Catalytic polycyclization via β-hydride elimination 
 Oxidation of the stable divalent (triphos)Pt
+
-R organometallic compounds by 
electrophilic fluorinating reagents led to the product of a stereoretentive C3-fluorination of 
the R group.  These reactions are believed to proceed by initial two electron oxidation of the 
Pt organometallic by F
+
 to give a Pt(IV) fluoride intermediate which underwent rapid and 
stereoretentive C-F bond forming reductive elimination.
68
  Replacement of the triphos ligand 
in this system with a bulky bisphosphine ligand slowed beta hydride elimination enough that 
catalytic cyclization/fluorination scheme for polyene substrates could be developed.  These 
reactions produced fluorinated products in good yields and enantioselectivities with the 
xylyl-phanephos ligand (Figure 1.37).
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Figure 1.37:  Catalytic cyclization/fluorination 
 Heteroatom terminating substrates were efficiently cyclized in both stoichiometric 
and catalytic schemes, however, the more challenging alkene terminating substrates remained 
untested.  Stoichiometric cyclization of these substrates proved significantly more 
challenging, long reactions times were observed despite optimized conditions that required 
two equivalents of substrate and multiple equivalents of base.  Under these conditions, a 
variety of substrates would be cyclized, including those that terminate in both a 6-endo and a 
6-exo fashion (Figure 1.38).  In the 5-exo terminating case, a Wagner-Meerwein rearranged 
product was observed, the result of a hydride and methyl shift to form a more 
thermodynamically stable tetrasubstituted alkene (Figure 1.39).
64
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Figure 1.38:  Stoichiometric polyene cyclization 
 
Figure 1.39:  Wagner-Meerwein rearrangement of 5-exo terminating substrate 
 Attempts to shift these polyene substrates into a catalytic manifold proved 
challenging as slow and incomplete reactions were the norm.  Optimization of conditions 
produced reactions which consumed starting material, but formed multiple isomers of 
products resulting in low isolated yields (Figure 1.40).
70
 
 
Figure 1.40:  Catalytic polyene cyclization 
Oxidative Functionalization of M-C Bonds 
 The introduction of new functional groups in transition metal catalyzed pathways 
often relies upon oxidation of the metal centre.  The bond forming reductive elimination from 
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higher oxidation species remains one of the most common and effective method for 
derivatizing M-C bonds.
71
  While oxidative addition has been the subject of intense study and 
generally proceeds via an SN2 mechanism, the reductive elimination of C-X bonds proceeds 
by the microscopic reverse, involving dissociation from an 18 electron species prior to SN2-
type attack to reduce the metal and liberate the product. 
72
 
 
Figure 1.41:  Shilov cycle 
 Much of the mechanistic work on reductive elimination has been performed on Pt 
complexes as their slow rates of ligand exchange simplify mechanistic study.  Early work 
involved study of the Shilov
73
 cycle in which both C-O and C-Cl bond forming reductive 
elimination from Pt(IV) are possible (Figure 1.41).
74
  In a thorough mechanistic study, 
Bercaw reported that both the formation of methanol and methyl chloride are the result of 
SN2 type attack upon the methyl group.  This was shown experimentally as C-Cl reductive 
elimination from Pt-alkyl model compounds led to an inversion of configuration at carbon.
75
 
It has previously been reported that reductive elimination from L2PtMe3X yielded 
exclusively ethane, the result of C-C reductive elimination from the Pt(IV) complex.
76
  In this 
case, use of monodentate phosphine ligands allowed for initial phosphine dissociation, prior 
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to C-C reductive elimination from the 5-coordinate complex (Figure 1.42).  While addition of 
excess iodide had no effect, addition of phosphine significantly slowed the reaction. 
Figure 1.42:  Redutive elimination of ethane from 5 coordinate intermediate 
Seminal work on the reductive elimination of C-X bonds from Pt(IV) was performed 
by Goldberg in the mid 90’s.77  Replacement of the monodentate phosphines with bidentate 
dppe, yielded a vastly different system.  In this case, phosphine dissociation was limited by 
the chelate effect, allowing for competitive dissociation of iodine, which could subsequently 
attack a methyl group, resulting in MeI formation.  The reverse reaction, oxidative addition 
of MeI to (dppe)PtMeI was possible, thus setting up an equilibrium.  The reversible nature of 
the reductive elimination of MeI was verified by the addition of NaI, which inhibited the 
formation of ethane.  Over time, the Pt(IV) species was converted to (dppe)PtMeI, the result 
of the reductive elimination of ethane from the same 5-coordinate intermediate (Figure 
1.43).
77a
   
 
Figure 1.43:  Reductive elimination pathways 
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 The majority of studies have supported the SN2 type reductive elimination from 5-
coordinate complexes, however, notable exceptions have been observed with Rh
78
 and Pt.  
We have recently reported the C-F bond forming reductive elimination from Pt 
organometallic compounds.  Oxidation of the Pt(II) alkyl species with XeF2 resulted in 
formation of a Pt(II)-F and the stereoretentive fluorinated product, likely the result of a direct 
reductive elimination from a Pt(IV)-F (Figure 1.44).
68
  While no Pt(IV) intermediates were 
observed in these reactions, several similar Pt(IV) fluorides have been isolated.
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Figure 1.44:  Stereoretentive C-F reductive elimination 
 The direct reductive elimination of C-Cl from Pt(IV) has also been observed.  
Oxidation of the doubly cyclometalated Pt(II) complex formed a mixture of cis and trans 
isomers of the Pt(IV) complex.  While the trans isomer proved relatively stable, warming a 
solution of the cis isomer resulted in the formation of a new Pt(II) species.  This proved to be 
the result of the reductive elimination of C-Cl which then datively bonds to the Pt centre.  
Once again, the reaction rate proved independent of additional chloride, suggesting a direct 
reductive elimination (Figure 1.45).
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Figure 1.45:  Stereoretentive C-Cl reductive elimination 
In the case of Rh, oxidative addition of methyl iodide to a Rh(I) pincer complex 
resulted in formation of a stable, five coordinate Rh(III)-alkyl complex.  Placing this 
complex under an atmosphere of CO resulted in highly steric dependent reactivity.  When the 
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phosphine groups contained isopropyl substituents, addition of CO formed a pair of six 
coordinate Rh(III) complexes.  However, when the isopropyl substituents were replaced with 
t-butyl groups, addition of CO resulted in reductive elimination of methyl iodide and 
formation of the Rh(I) carbonyl complex (Figure 1.46).  Addition of tetrabutylammonium 
iodide to the reaction left the reaction rate unchanged, making an SN2-type mechanism 
unlikely.
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Figure 1.46:  Stereoretentive C-I reductive elimination from Rh(III) 
 Functionalization of metal carbon bonds via 2-electron oxidation mechanisms has 
been well studied and applied across a broad range of metals.  Much less common, is the 
functionalization of metal carbon bonds which occurs by a single electron oxidation of the 
metal.  While reports of this type have varied in both metal and ligand selection, single 
electron oxidation has often resulted in the formation of a carbon centered radical which can 
undergo further reaction to form halogenated, oxygenated or further reduced organic species 
depending on the choice of oxidant and atmosphere. 
 Early work involving the generation of alkyl radicals from organometallic complexes 
was perfomed by Kochi with several different metals.  Formation of alkyl bromides from the 
reaction of mercury, palladium and zirconium organometallic complexes with copper (II) 
bromide was studied and revealed a mechanism involving homolytic cleavage of the metal 
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alkyl bond in all cases.  The involvement of a radical mechanism was confirmed by the 
stereochemical scrambling observed in the formation of the alkyl bromide, a result of the 
reaction of the free radical with copper (II) bromide (Figure 1.47).
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Figure 1.47:  Bromination of Pd and Hg-bonds 
 In the case of Pt(II) organometallic compounds, an in depth study revealed an 
oxidative process highly dependent upon the donating ability of both ligand and alkyl group.  
Several dialkyl(bisphosphine)platinum(II) complexes were oxidized in the presence of 
hexachloroiridate and produced products resulting from single and double electron oxidation 
of the Pt centre.  In the case of methyl groups, oxidation of Me2Pt(PMe2Ph)2 produced Pt(IV) 
compounds.  Replacement of the dimethylphenylphosphine ligands with triphenylphosphine 
resulted in competitive formation of Pt(IV) compounds and methylplatinum (II) compounds 
accompanied by MeCl - the result of homolytic cleavage of a Me-Pt bond and interception of 
the Me radical by hexachloroiridate.  Replacement of the methyl groups with ethyl groups in 
both the dimethylphenylphosphine and triphenylphosphine complex allowed for a clean 
single electron oxidation, producing EtCl and monoethylplatinum (II) (Figure 1.48).  While 
both reactions provided the same products, the rate of oxidation of the triphenylphosphine 
complex was slower than that of the dimethylphenylphosphine complex.  The involvement of 
alkyl radicals was confirmed by spin trapping and oxygen scavenging experiments.
82
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Figure 1.48:  Donor effects on the oxidation of Pt(II) compounds 
 Later studies on the single electron oxidation of lead, tin and mercury compounds 
focused on the oxidation event itself.  The oxidation was probed using a series 
trisphenanthroline iron(III) complexes which varied in reduction potential according to their 
substitution.  Oxidation of the lead, tin and mercury organometallic complexes with these 
coordination complexes of iron revealed a second order rate constant which was linearly 
dependent upon the reduction potential of the oxidant, showing no deviation for steric 
effects.  These data suggested a strictly outer-sphere oxidation process.  In contrast to the 
iron(III) oxidants, application of hexachloroiridate as the oxidant in the same reactions, 
revealed significantly faster oxidations than those predicted solely based upon their reduction 
potential.  Oxidations with the hexachloroiridate also proved sensitive to steric effects, 
pointing toward an inner sphere electron transfer process.  While the iron complexes also 
served to oxidize the subsequently formed radical, the hexachloroiridate provided the alkyl 
chloride product (Figure 1.49).
83
 
 
Figure 1.49: Inner and outer sphere one electron oxidation of organostannanes 
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Baird has also studied the single electron oxidation of both iron
84
 and ruthenium
85
 
complexes.  In the case of iron, two possible reaction pathways could be followed.  Oxidation 
with copper (II) halides resulted in formation of an ion paired complex, the fate of which was 
dependent upon the alkyl group.  In the case of methyl and benzyl substituents, single 
electron oxidation with a copper (II) halide resulted in the breakdown of the ion pair via an 
SN2 type attack of halide upon the alpha carbon, generating MeX or PhCH2X with inversion 
of configuration.  When the alkyl group was n-Bu or Me3CCH2CH2 the ion pair broke down 
via homolytic cleavage of the iron carbon bond, the alkyl radical then reacts with the copper 
(II) halide to form the alkyl halide.
84
  
 Oxidation of ruthenium organometallics with copper (II) halides provided the organic 
radical which was once again halogenated with excess copper halide.  Electrochemical 
studies revealed that the ruthenium complexes were more challenging to oxidize and reacted 
accordingly.  Reaction of the ruthenium complexes with mercury (II) halides resulted in a 
transmetallation reaction, forming the organomercury complexes in quantitative yield.
85
 
 Trogler has also reported the chemical and electrochemical single electron oxidation 
of palladium organometallic compounds.
86
  A series of dialkyl palladium compounds 
underwent single electron oxidation and homolytic Pd-C bond cleavage induced either 
electrochemically or chemically with ferrocenium.  A PCP pincer palladium methyl complex 
was also studied, revealing selective homolytic cleavage of the palladium methyl bond 
(Figure 1.50).  Electrochemical studies of the Pd complexes revealed that despite the uphill 
electron transfer process between Pd and ferrocenium, the irreversible nature of the process 
allowed for facile electron transfer. 
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Figure 1.50:  Single electron oxidation of Pd pincer complex 
Research Objectives 
Biomimetic approaches to the cyclization in acyclic polyene substrates have struggled 
to replicate the complexity observed in their enzyme mediated counterparts.  These reactions 
have long suffered from a lack of selectivity, premature termination and an inability to 
duplicate the structural rearrangements observed in nature.  This gap between nature and 
synthetic approaches has prompted the design of elaborate systems to overcome the inherent 
problems observed in the laboratory. 
Of particular interest is the synthesis of C3-oxygenated polycycles.  This structural 
motif is commonly observed in nature and has as its source the oxygen of oxidosqualene.  
While effective methods exist for their synthesis, installation of the oxygen moiety has 
occurred exclusively prior to cyclization, generally in the form of an epoxide.  This has 
necessitated the synthesis of chiral substrates in to achieve selectivity in the products, making 
catalyst controlled cyclization and subsequent installation of the C3-oxygen an attractive 
alternative.   
Our previous efforts in the cyclization of polyene substrates have proven effective for 
the stoichiometric synthesis of C3 platinated organometallic complexes from both 
heteroatom and alkene terminating substrates.  Catalytic variants of these reactions have been 
limited by the formation of complex mixtures of products and in several cases, a limited 
substrate scope. 
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We present herein, efforts toward the development of new methods for the post-
cyclization oxygenation and halogenations of polycycles under catalyst control.  We also 
report the development and application of a versatile catalyst for the cyclization of polyenes, 
designed to enable the atom economical cycloisomerization of a wide range of polyene 
substrates. 
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CHAPTER 2:  STOICHIOMETRIC HALOGENATION OF PT-C BONDS
*
 
Introduction   
When considering the reductive elimination of C-X bonds from high valent metal 
centres, two modes of reactions are possible: stereoretentive reductive elimination in which 
configuration is retained, and SN2 type reductive elimination in which an inversion of 
configuration is observed.  The majority of studies on C-X bond forming reductive 
elimination have involved formation Me-X bonds, a process in which the stereochemical 
information is lost since both retentive and SN2-type reductive elimination mechanisms form 
the same identical product. 
The stability of (triphos)Pt-R
+ 
complexes toward acid has allowed for the isolation of 
unique Pt alkyl compounds where the alkyl is a complex multicyclic structure. Formation of 
the diastereomerically pure Pt-alkyl compounds generated from a polyene cyclization, 
provide ideal subjects for study of C-X bond forming reductive elimination.  In contrast to 
the reductive elimination of MeX bonds, the stereogenicity of the carbon center and the 
diastereomeric purity of this compound allows for the generation of two different and 
distinguishable diastereomeric products depending upon the mechanism of reductive 
elimination (Figure 2.1). 
                                               
*
Portions of this chapter were adapted with permission from Geier, M.J.; Gagné, M.R. Organometallics, 2013, 
32, 380 and Geier, M.J.; Gagné, M.R., in preparation. 
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Figure 2.1:  Possible C-X reductive elimination pathways 
We have previously reported the first stereoretentive C-F bond forming reductive 
elimination from a proposed Pt(IV) intermediate.
1
  While this stereochemical outcome was 
surprising, as C-X reductive elimination generally proceeds in a step-wise stereoinvertive 
fashion,
2
 the poor nucleophilicity of fluoride was thought to perhaps contribute to this 
phenomenon.   
The successful fluorination
1
 and β-hydride elimination3 reactions of polycyclic Pt-
alkyl compounds led us to the explore the possibility of developing new Pt-C bond 
functionalizing reactions and turnover mechanisms through mechanistic studies on pre-
isolated Pt-alkyl intermediates.  With this long-term goal in mind, further exploration of the 
reductive elimination from the Pt-alkyl complex was undertaken. 
Results 
We began our studies by investigating the chlorination, bromination and iodination of 
compound 2.1 to determine whether a stereoretentive (akin to the fluorination chemistry)
1
 or 
invertive reductive elimination process would be operative. Oxidation of compound 2.1 with 
two equivalents of a halosuccinimide reagent (n-bromosuccinimide and n-chlorosuccinimide) 
again - in analogy to the XeF2 work - resulted in stereoretentive reductive elimination of the 
C-X bond.  While C-F reductive elimination proceeded rapidly with XeF2, C-Cl and C-Br 
bond forming reductive elimination proved significantly slower, three hours in the case of the 
bromide and 18 hours for the chloride.  While yields were a moderate 43% for the chloride, 
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and 58% for the bromide, diastereoselectivity of the reaction was good, producing the 
products in greater than 10:1 dr.  In the case of iodine (I2), oxidation proceeded in less than 
five minutes, producing the stereoretentive iodide in 89% yield with greater than 10:1 dr 
(Figure 2.2).  Despite convenient monitoring by 
31
P NMR spectroscopy, no intermediates 
were observed, suggesting slow oxidation of Pt(II) to Pt(IV) followed by rapid reductive 
elimination from the proposed Pt(IV) intermediate.  In each case, the Pt-product was 
determined to be (triphos)Pt-X
+
 (X = Cl, Br, I) as determined from 31P NMR spectroscopy.  
In each case, the coupling constant of the phosphine trans to the halide was ~3 000 Hz, 
characteristic of a (triphos)PtX
+
 complex.  
 
 
Figure 2.2:  Stereoretentive C-X bond forming reductive elimination 
 Starting from the four coordinate Pt(II) complex, oxidation with X
+
 reagents is 
believed to generate a dicationic Pt(IV)-halide complex with a sixth coordination site left 
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vacant or occupied by solvent.  This complex is likely to be highly unstable as the soft 
phosphine donor ligands struggle to stabilize hard, high-oxidation state metal complexes such 
as Pt(IV).
4
  As a consequence of its high reactivity, this complex will then undergo rapid, 
metal-based reductive elimination, resulting in the observed stereoretentive products (Figure 
2.3).  Given the electron deficient nature of a dicationic Pt(IV) complex it is perhaps not so 
surprising that X
-
 loss (to a tricationic, formally four coordinate Pt(IV) species) and re-
addition is not a competitive mechanism of reductive elimination.  In most cases where the 
invertive/SN2 mechanism is invoked for R-X reductive elimination the charge on the metal is 
such that the overall charge on the putative intermediate is not nearly so high. 
 While the aversion of F
-
 to behave as a nucleophile in an SN2-type reaction could 
explain the stereoretentive fluorination, the larger halides (Br
-
, I
-
) are known to be 
sufficiently nucleophilic to engage in such reactivity,
5
 making their C-X bond forming, 
stereoretentive reductive elimination that much more surprising.  While stereoretentive C-Cl 
bond forming reductive elimination has recently been reported,
6
 these represent the first 
cases of stereoretentive C-Br and C-I bond forming reductive elimination from Pt(IV). 
 
Figure 2.3:  Mechanism of stereoretentive C-X bond formation 
 The use of halonium reagents as two electron oxidants proved effective for converting 
Pt(II) to Pt(IV) resulting in formation of the C3-halogenated products, however, we became 
interested in C3-oxygenated compounds, a structural motif found in numerous natural 
products.
7
  To access such products, we contemplated methods to achieve C-O bond forming 
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reductive elimination.
8
  Recent organometallic chemistry of high valent Pt and Pd complexes 
with electrophilic fluorinating reagents has proven to be quite complex,
9
 often involving 
competing reductive elimination processes.
10
  The significant kinetic barrier to C-F bond 
forming reductive elimination has made electrophilic fluorinating reagents an attractive by-
standing oxidant, wherein F
+
 serves as the oxidant but does not participate in bond forming 
reductive elimination, an approach that has shown the ability to promote a variety of 
alternative reductive elimination processes.
11
 
We envisioned a process through which Pt oxidation with an electrophilic 
fluorinating reagent would produce a transient Pt(IV) complex, which, in the presence of a 
suitable oxygen nucleophile could undergo an SN2 type C-O bond forming reaction.  
Attempts to use XeF2 in the role of by-standing oxidant to achieve selective C-O bond 
forming reductive elimination produced unexpected results.  Addition of 3 eq. of XeF2 to a 
solution of 2.1 and 10 eq. tetrabutylammonium acetate (TBAOAc) in acetonitrile consumed 
the starting material, however, the desired C3-acetate was not observed.  In place of the 
acetate, we discovered that the invertive C3-fluorinated product was now the preferred 
product (Table 2.1).  To better determine the role of acetate, its concentration was varied, at a 
single equivalent of TBAOAc, a slight preference for the stereoretentive product was 
observed (47% to 36%), while at 5 and 10 equivalents of TBAOAc, a strong preference for 
the invertive product (58% to 5% and 35% to 3% respectively), suggesting an important role 
for TBAOAc. 
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Table 2.1:  Fluorination in the presence of TBAOAc 
 
 In the presence of acetate, the previously reported direct reductive elimination 
pathway
1
 from the five coordinate Pt(IV)-fluoride could be nearly shut off.  Oxidation of the 
Pt(II)-alkyl complex by XeF2 results in formation of the five coordinate Pt(IV) fluoride, 
however, in the presence of acetate, we surmised that the five coordinate Pt(IV)-fluoride can 
be quickly trapped (more effectively at high TBAOAc concentrations) to form a 6-
coordinate, cationic complex, preventing the previously reported stereoretentive reductive 
elimination.  From this six coordinate complex, there are two possible pathways to arrive at 
the stereoinvertive product: path A:  fluoride dissociation to form a five coordinate Pt-acetate 
and attack of the fluoride at C3, or path B: direct attack of fluoride (XeF2 serves as a kinetic 
source of F
+ 
first and and F
- 
second)
12
 at C3 of the six coordinate complex (Figure 2.4). 
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Figure 2.4:  Possible reductive elimination pathways with XeF2 and TBAOAc 
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To further investigate this unexpected switch in reductive elimination mechanism, 
several similar processes were examined.  Addition of tetrabutylammonium bromide in place 
of the tetrabutylammonium acetate allowed for formation of C3-brominated products.  At 
one equivalent of tetrabutylammonium bromide, the stereoretentive C3-fluoride remained the 
major product at a 51% yield.  At 2 equivalents TBAB, 32% of the retentive fluoride, 19% of 
the invertive bromide and 4% of the retentive bromide formed.  At 5 equivalents TBAB 31% 
of the retentive fluoride, 31% of the invertive bromide and 21% of the retentive bromide 
formed.  This data provide a clear indication that brominated products are preferred at higher 
loadings of TBAB. 
Table 2.2:  Fluorination in the presence of TBAB 
 
While formation of the stereoretentive fluoride likely proceeds through the 5 
coordinate complex, formation of the invertive bromide is most easily explained as 
proceeding through two different mechanisms.  Attack of Br
- 
on the 5 coordinate complex 
(path A) or trapping of the five coordinate complex with Br
-
 to form the 6 coordinate 
complex, which could then undergo bromide attack (path B).  Formation of the 
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stereoretentive bromide could occur through two different mechanisms:  from dissociation of 
fluoride from the 6-coordinate complex, which could then undergo stereoretentive C-Br 
reductive elimination, akin the reaction of 2.1 with NBS (Figure 2.5), or conversion of Br
-
 to 
Br
+
 through reaction with XeF2. 
 
Figure 2.5:  Possible reductive elimination pathways with XeF2 and TBAB 
 54 
 
 The kinetic barrier to C-F bond forming reductive elimination is known to allow 
competing processes to occur with electrophilic fluorinating reagents.
9,11
  With this in mind, 
we explored the use of NBS as oxidant to ascertain if this mechanistic switch occurred 
exclusively with electrophilic fluorinating reagents.  Use of N-bromosuccinimide as oxidant 
and tetrabutylammonium bromide (TBAB) as the nucleophile also produced a mixture of 
invertive and retentive bromides.  At 1 equivalent of TBAB, equal amounts of invertive and 
retentive bromide were formed at 19% a piece.  At 2 equivalents 2 TBAB, the ratio remained 
similar, however, both were formed in greater yield, 33% of the retentive and 27% of the 
invertive.  At 5 equivalents of TBAB, the invertive product was favored by nearly a 2:1 ratio 
at 23% to 12%.  While the variations in yield were unexpected, the increasing amounts of the 
invertive product suggest a link between formation of the invertive and the concentration of 
TBAB. 
Table 2.3:  Bromination in the presence of TBAB 
 
While the retentive bromide is likely produced from reductive elimination from the 5-
coordinate complex, the invertive product can once again be produced in two different ways:  
bromide attack on a 5 coordinate (path A) or 6 coordinate (path B) complex (Figure 2.6).  
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While a 6-coordinate complex is likely to be favored at higher bromide concentrations, these 
data do not provide sufficient evidence for a 5 vs. 6 coordinate mechanism. 
 
Figure 2.6:  Possible reductive elimination pathways with NBS and TBAB 
Discussion 
This study has provided clear evidence that the process of reductive elimination from 
proposed Pt(IV) intermediates can proceed by two different mechanisms, each of which leads 
to a different favored diastereomer in the product.  In the absence of suitable nucleophiles, 
formation of the stereoretentive products is likely the result of the instability of the 5 
coordinate complex.  While dissociation of X
-
 and SN2 type attack is generally favored in 
most late metal organometallic compounds, in this case, dissociation of X
- 
would produce a 
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14 electron, 4-coordinate, tricationic Pt(IV) complex (Figure 2.6).  The instability of such a 
putative intermediate would seem to reduce the likelihood of proceeding in this fashion. 
 
Figure 2.7:  Reductive elimination from 5-coordinate complex 
 A mechanistically relevant process has recently been reported by Sanford et. al in 
which C-F bond forming reductive elimination from Pd(IV) produces an alkyl fluoride.  The 
authors concluded that ligand (pyridine) dissociation from a 6 coordinate complex takes 
place prior to reductive elimination from a similar 5 coordinate complex.  While the authors 
were unable to differentiate between invertive and retentive reductive elimination, they 
favored the retentive pathway due to the poor nucleophilicity of F
-
 and unlikely dissociation 
of F
-
 from the 5 coordinate complex.
13
  The observation of invertive F
-
 reductive elimination 
pathways in the present suggests that this possibility may indeed be feasible. 
 
Figure 2.8:  Sanford’s C-F reductive elimination from Pd(IV) 
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In the case of the stereoinvertive reductive eliminations, two different pathways are 
possible in each case: 1) nucleophilic attack on a 5 coordinate complex, or 2) nucleophilic 
attack on a 6 coordinate complex (Figure 2.9).  While either or both processes may be 
operative, previous work by Goldberg, Puddephatt and others would suggest that reductive 
elimination proceeds by nucleophilic attack upon
 
the 5 coordinate complex.
2a,b,9,14
   
 
Figure 2.9:  Possible paths to stereoinvertive reductive elimination 
While X
-
 dissociation from a 5 coordinate complex is likely to be highly disfavored 
(see above), the coordination of a nucleophile (OAc
-
, Br
-
) is likely to provide sufficient 
electron density to allow for halide dissociation and SN2 type reductive elimination.  While in 
the absence of a nucleophile, dissociation would produce a 4 coordinate, tricationic Pt(IV) 
intermediate, the addition of a nucleophile would produce a more feasible 5-coordinate 
dicationic species. 
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Figure 2.10:  Comparison of possible intermediates 
 The ability to manipulate the mechanism of reductive elimination from Pt(IV) has 
provided a means through which to control the diastereoselectivity of the halogenated 
product.  This unexpected deviation from standard SN2-type behavior has provided evidence 
that this process may be more complicated than previously believed.  While we have been 
unable to determine the nature of the coordination sphere from which these reductive 
elimination mechanisms take place, study of their role in this process will provide valuable 
insight.  While we have previously reported catalytic, stereoretentive cyclization/fluorination 
of polyenes,
15
 we have thus far been unable to translate this to catalytic manifold, selectively 
proving the other fluoride diastereomer. 
Experimental Section 
All air and moisture sensitive procedures were performed using an MBraun glovebox or 
standard Schlenk line techniques.  Commercially available reagents were used without 
further purification.   Acetonitrile was distilled from CaH2.  NMR spectra were collected on a 
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Bruker 600 MHz Avance spectrometer and referenced to residual solvent peaks.  Compounds 
2.1,
16
 2.5
1
 and 2.7
17
 have been reported.  HRMS was performed by Dr. Mee-Kyung Chung at 
the University of North Carolina at Chapel Hill. 
General Procedure for Oxidation Reactions 
The oxidant of choice was added to a stirring solution of 2.1 (8 mg, 0.04 mmol) in CD3CN 
(0.7 mL).  For reactions involving tetrabutylammonium salts, the salt was added prior to the 
oxidant.  NMR yields were determined in reference to an internal standard by 
1
H or 
19
F NMR 
(4-methylanisole for reactions with TBAB and 1-fluoro-3,5-dimethoxybenzene for reactions 
with TBAOAc) 
Compound 2.2: 
 
2.2:  
1
H NMR (600 MHz, CDCl3): δ 7.12 (m, 1H), 7.06 (m, 1H), 6.86 (m, 1H), 6.80 (m, 1H), 
3.99 (m, 1H), 2.63 (m, 1H), 2.53 (m, 1H), 2.29 (br, 2H), 2.05 (m, 1H), 1.92 (m, 1H), 1.86 (m, 
1H), 1.75 (m, 1H), 1.59 (m, 1H), 1.22 (s, 3H) ppm. 
13
C NMR (152 MHz, CDCl3): 153.4, 
129.6, 127.7, 121.3, 120.2, 117.5, 75.7, 57.7, 40.1, 39.4, 38.9, 34.3, 28.9, 16.6 ppm. HRMS 
(ESI) C14H17ClO [M+H]
+
/z calc. 237.1041, found 237.1045. 
Compound 2.3: 
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2.3:  
1
H NMR (600 MHz, CDCl3): δ 7.10 (m, 1H), 7.02 (m, 1H), 6.84 (m, 1H), 6.78 (m, 1H), 
4.08 (m, 1H), 2.60 (m, 1H), 2.50 (m, 1H), 2.36 (br, 2H), 2.00 (m, 2H), 1.90 (m, 1H), 1.60 (m, 
2H) 1.21 (s, 3H) ppm. 
13
C NMR (152 MHz, CDCl3): 153.4, 129.6, 127.7, 121.3, 120.2, 
117.5, 75.6, 48.9, 41.0, 40.5 40.0, 35.2, 28.8, 16.6 ppm. HRMS (ESI) C14H17BrO [M+H]
+
/z 
calc. 281.0536, found 281.0534. 
 
 
Compound 2.4: 
 
2.4: 
1
H NMR (600 MHz, CDCl3): δ 7.10 (m, 1H), 7.02 (m, 1H), 6.83 (m, 1H), 6.77 (m, 1H), 
4.17 (m, 1H), 2.59 (br, 1H), 2.40-2.52 (m, 3H), 2.17 (m, 1H), 1.82-1.91 (m, 3H), 1.71 (m, 
1H), 1.21 (s, 3H) ppm. 
13
C NMR (152 MHz, CDCl3): δ 153.3, 129.6, 127.7, 121.3, 120.16, 
117.5, 75.6, 43.4, 42.1, 41.5, 37.6, 28.6, 25.5, 16.6 ppm.  HRMS (ESI) C14H17IO [M+H]
+
/z 
calc. 329.0397, found 329.0395. 
Compound 2.6: 
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2.6:
 1
H NMR (600 MHz, CD2Cl2):  δ 7.11-7.06 (m, 2H), 6.84 (m, 1H), 6.77 (m, 1H), 4.90 
(dm, 1H, JH-F = 48Hz), 2.62 (dd, 1H, J = 16.8 Hz, 5.4 Hz), 2.47 (dd, 1H, J = 16.8 Hz, 13.2 
Hz), 2.25 (m, 1H), 2.15 (m, 2H), 2.00 (m, 1H)1.83-1.65 (m, 2H), 1.46-1.33 (m, 1H), 1.17 (s, 
3H) ppm.  
13
C NMR (152 MHz, CD2Cl2): δ 153.5, 129.5, 127.3, 121.9, 119.7, 117.1, 87.6 (d, 
JC-F = 168 Hz), 76.1, 34.7 (d, JC-F = 21.1 Hz), 33.4, 33.3, 28.5, 28.4 (d, JC-F = 21.1 Hz), 15.4 
ppm.  
19
F NMR (565MHz, CD2Cl2):  -182.2 ppm.  HRMS (EI) C14H18FO [M + H]
+
/z calc. 
221.1336 found 221.1331. 
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CHAPTER 3:  ONE ELECTRON OXIDATION OF Pt-ALKYL COMPOUNDS
*
 
Introduction 
The two electron oxidation of platinum alkyl complexes with halonium reagents 
provided access to C3-halogenated compounds with controllable diastereoselectivity.  
Despite attempts to employ these halonium reagents as spectator oxidants, no oxygenated 
products were observed.  In an attempt to access these desired C3-oxygenated compounds, 
several other oxidative routes were explored. 
Recent work from the Goldberg
1
 and Britovsek
2
 groups disclosed the photochemical 
reaction of Pt and Pd-Me complexes with oxygen to generate the O2 insertion products.  
These reactions have been proposed to proceed via two different mechanisms.  In the case of 
the diaminoterpyridine Pt-Me complex, the complex itself has been shown to act as an 
oxygen sensitizer, converting triplet oxygen to the more reactive singlet oxygen, enabling 
insertion of O2 to proceed.
2
  Continued exposure of the complex to light resulted in formation 
of formaldehyde and the platinum hydroxide complex (Figure 3.1). 
 
 
                                               
*
 Portions of this chapter were adapted with permission from Geier, M.J.; Gagné, M.R. Organometallics, 2013, 
32, 380 
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Figure 3.1:  Insertion of singlet oxygen to Pt-Me bond 
Goldberg has reported a light dependent radical chain mechanism for the insertion of 
O2 into a Pd-Me bond of (bpy)PdMe2.
1b
  Detailed mechanistic study revealed that initiation 
occurred by homolysis of the radical initiator AIBN to form an alkyl radical which was 
rapidly intercepted by oxygen.  The alkyl peroxy radical then underwent a free radical 
substitution reaction with (bpy)PdMe2 to liberate a methyl radical.  Propagation then 
occurred by interception of this methyl radical by oxygen and reaction with a second 
equivalent of (bpy)PdMe2 to form a five coordinate, Pd(III) complex which then liberated a 
methyl radical and formed the observed O2 insertion product (Figure 3.2).  These reports of 
Pt and Pd alkyl reactivity under photochemical conditions formed the starting point for the 
study described in this chapter. 
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Figure 3.2:  Goldberg’s insertion of O2 into Pd-Me bond 
Stoichiometric Reactions 
Initial studies focused on the photochemical reactivity of Pt-alkyl complex 3.1 under 
an atmosphere of oxygen.  Consumption of starting material was monitored by 
31
P NMR and 
organic products were identified by gc/ms.  Exposure of the complex to a compact 
fluorescent light (CFL) bulb under oxygen in acetonitrile resulted in formation of the desired 
C3-ketone 3.2 in a 60% yield.  In contrast to the report of Britovsek
2
 in which the platinum 
hydroxide product was formed, extensive decomposition of the Pt complex was observed.   
Reactions were slow, taking approximately 18 hours for complete consumption.  
Addition of the radical initiator AIBN resulted in slightly shorter reaction times and a small 
bump in yield to 67%, while the radical inhibitor BHT resulted in longer reaction times and a 
lower yield of the ketone product at 40%, mildly suggestive of a radical mechanism (Table 
3.1).  Despite formation of the desired oxygenated product in these reactions, decomposition 
 67 
 
of the Pt initiator precluded development of a catalytic scheme for the 
cyclization/oxygenation of polyenes. 
Table 3.1:  Additive effect in photochemical oxygenation reactions 
 
Eager to explore milder conditions for generation of the C3 oxygenated product, 
chemical oxidants were explored following reports of Pt-Me
3
 and Pd-Me
1b,4
 bond homolysis 
from the +3 oxidation state.  The radical initiators AIBN and benzoyl peroxide were first 
examined.  Initiation of the reactions required elevated temperatures, multiple equivalents of 
the initiator and extended reaction times.  Formation of the ketone product was once again 
observed, albeit in low yield.  Once again, extensive decomposition of the Pt initiator was 
observed. 
In an attempt to effect a cleaner oxidation reaction, metal oxidants were explored.  
Copper (II) chloride, commonly used to oxidize Pd(0) to Pd(II) in a stepwise fashion in the 
Wacker process was chosen as the single electron oxidant.  Reaction of 3.1 with a single 
equivalent of CuCl2 in acetonitrile resulted in 50% consumption of the starting material in 
under 5 minutes, extended reaction times provided no further reaction.  Analysis of the 
organic products by gc-ms revealed a 1:1 ratio of the two C3-chloride diastereomers, with 
concominant formation of (triphos)PtCl
+
.  Reaction of 3.1 with two equivalents of CuCl2 
provided complete consumption of starting material, resulting in a 54% isolated yield of a 1:1 
mixture of chloride diastereomers.  Application of two equivalents of CuBr2 as oxidant, 
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resulted in a 66% isolated yield of the C3-brominated product with a dr of 1.8:1 with a 
preference for the invertive brominated product as established by 
1
H NMR coupling 
constants (Table 3.2). 
Table 3.2:  Halogenation of Pt-alkyl with CuX2 
 
The formation of a mixture of diastereomers suggested the involvement of a free 
radical process.  The proposed mechanism involves initial one electron oxidation of the 
Pt(II)-alkyl to Pt(III), which initiates Pt-C bond homolysis, forming the (triphos)PtX
+
 and a 
C3-radical.  The C3 radical can then be intercepted in a non-diastereoselective fashion by a 
second equivalent of CuX2 to form the C3-halide (Figure 3.3).  Kochi has measured the rate 
constant for the interception of alkyl radicals by CuBr2 to be ~4x10
9
 M
-1
s
-1
,
5
 indicating rapid 
quenching of the free radical. 
 
Figure 3.3:  Proposed mechanism for the halogenation of 3.1 with CuX2 reagents 
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 The successful generation of alkyl radicals suggested that oxygenation may indeed be 
possible (Figure 3.4).  In an attempt to thwart the undesired bromination pathway, the 
reagents were combined under 2 atm of oxygen in acetonitrile.  Analysis of the organic 
products by gc-ms revealed 37% of the C3-ketone, 49% of a mixture of diastereomers of the 
C3-alcohol and a 14% yield of the bromide diastereomers.  Isolation of the oxygenated 
products resulted in a 63% yield with a ketone:alcohol ratio of 1:1.  While initially 
confounded by the mixture of oxygenated products due to the observation of formaldehyde 
by Britovsek and the formation of the C3-ketone under photochemical conditions, the 
mixture can be explained by a simple free radical mechanism, first proposed by Russell
6
 to 
explain the reactivity of secondary radicals with O2, further supporting the proposed radical 
mechanism for halogenation. 
 
Figure 3.4:  Mechanism of oxygenation of Pt-C bond 
 Oxidation of the Pt(II)-alkyl by CuBr2 again results in eventual Pt-C bond homolysis, 
in this case, the alkyl radical can be intercepted by molecular oxygen in a non 
diastereoselective fashion to form the alkylperoxy radical.  Despite the comparable rate of 
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interception of free radicals by oxygen (3-5x10
9
 M
-1
s
-1
)
7
 and CuBr2 (~4x10
9
 M
-1
s
-1
),
5
 the 
increased pressure of O2  allowed for preferential oxygenation.  Alkylperoxy radicals have 
been shown to undergo Russell disproportionation
6,8
 through a six membered transition state 
to generate one equivalent of ketone and one equivalent of the alcohol and 
1
O2 (Figure 3.5). 
 
Figure 3.5:  Russell disproportionation of alkyl radical 
 Use of copper halides as the single electron oxidant under an increased pressure of 
oxygen provided the desired organic product, however, formation of (triphos)PtX
+
 prevented 
any exploration of a catalytic variant as (triphos)PtX
+
 complexes are unable to initiate 
polyene cyclization.  To solve this problem, we turned to Cu(OTf)2 in the hope that the 
weakly coordinating triflate may allow for catalytic reactions.  Addition of 1 equivalent of 
Cu(OTf)2 to a solution of 3.1 in acetonitrile resulted in immediate consumption of starting 
material and a 53% isolated yield of oxygenated products.  Addition of two equivalents of 
Cu(OTf)2 under the same conditions resulted in a 33% isolated yield of oxygenated products 
with a notable increase in the β-hydride elimination product.  In order to maximize the yield 
of oxygenated products, the reaction of 3.1 with 1 equivalent of Cu(OTf)2 was performed 
under 2 atm of oxygen which provided an 80% isolated yield of oxygenated products (Table 
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3.3).  To confirm molecular oxygen as the source of oxygen, reactions performed with 
rigorous exclusion of oxygen resulted in exclusive formation of the product of net β-hydride 
elimination.  This alkene product likely forms as a result of the oxidation of the alkyl radical 
by a second equivalent of Cu(OTf)2.  This reaction only occurs in the absence of copper 
halides and oxygen as the rate constant for oxidation of the alkyl radical by Cu(OTf)2 is 
significantly slower at (~2x10
7 
M
-1
s
-1
).
9
  Importantly, oxidations using Cu(OTf)2 provided 
clean formation of (triphos)Pt-NCMe
2+
.  While (triphos)Pt-NCMe
2+
 is incapable of initiating 
cyclization, its formation suggested a simple change in solvent may regenerate the catalyst. 
Table 3.3:  Optimization of oxygenation of Pt-alkyl 
 
Catalytic Studies 
Initial work toward a catalytic sequence focused on a change in solvent from 
acetonitrile to something less coordinating.  A dramatic solvent effect was quickly observed, 
as the stoichiometric oxidation reaction which takes seconds in acetonitrile did not proceed in 
the majority of solvents tested.  This phenomenon can be explained by the higher redox 
potential of copper(II) triflate in acetonitrile, due to the thermodynamic stability of the 
product copper(I) tetrakis acetonitrile complex.  Despite the lack of reactivity in nitroethane, 
a switch to nitromethane provided the desired oxidation, however, reaction times were 
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significantly slower than in acetonitrile, taking several hours to observe complete 
consumption of the Pt-alkyl (Table 3.4). 
Table 3.4:  Solvent effect on oxygenation of Pt-alkyl 
 
The rate of the oxidation reaction was impacted by the use of poorly coordinating 
ligands as additives.  In nitromethane, stoichiometric oxidation of the Pt-alkyl required 4 
hours for complete consumption of starting material.  Addition of 2 equivalents of 1-hexene, 
designed to mimic the presence of an excess of polyene substrate, dropped the reaction time 
to less than three hours.  Oxidation in the presence of pentafluorobenzonitrile, a poorly 
coordinating nitrile used previously in Pt catalyzed polyene cyclizations,
10
 further reduced 
reaction times to less the 1.5 hours (Table 3.5).  These results, particularly the rate 
enhancement in the presence of 1-hexene, suggested that oxidation in a catalytic manifold 
should proceed at a faster rate than those performed in a stoichiometric fashion. 
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Table 3.5:  Additive effect on oxygenation of Pt-alkyl 
 
To test the feasibility of a catalytic variant, oxidation of the Pt-alkyl was carried out 
under 1 atm of O2, upon complete consumption of starting material (verified by 
31
P NMR), a 
second equivalent of substrate and a second equivalent of copper (II) triflate were added.  
Monitoring of the reaction over time revealed consumption of the second equivalent of 
starting material, suggesting continued activity of the initiator. 
The use of copper(II) reagents as oxidants in organometallic chemistry has been 
especially fruitful.  The remarkable ability of copper(II) reagents to reoxidize Pd(0) to Pd(II) 
while using molecular oxygen as the terminal oxidant has allowed the use of catalytic 
quantities of Cu in many cases.  To test the ability of copper(II) triflate to engage in such a 
scheme, 0.4 eq. of Cu(OTf)2 was added to the Pt-alkyl in acetonitrile under an atmosphere of 
air.  Monitoring of the reaction revealed continued consumption of the starting material over 
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a period of several hours, reaching a maximum of 70% consumption, suggesting that despite 
slow and incomplete turnover, re-oxidation of Cu(OTf)2 was occurring in air (Table 3.6). 
Table 3.6:  Re-oxidation of Cu(OTf)2 
 
These stoichiometric reactions suggested a Pt(II)/Pt(III) catalytic cycle in which 
activation of the [(triphos)PtI]I precursor by halide abstraction with silver tetrafluoroborate 
would generate the catalyst.  Cyclization would form the Pt-alkyl complex and oxidation by 
copper(II) triflate would form a Pt(III)-alkyl which would undergo Pt-C bond homolysis to 
regenerate the catalyst, forming an alkyl radical and copper(I) triflate.  This radical could be 
quickly intercepted by oxygen and undergo Russell disproportionation to furnish the 
oxygenated products.  Re-oxidation of copper(I) triflate to copper(II) triflate by molecular 
oxygen would allow the use of a substoichiometric amount of copper (Figure 3.6). 
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Figure 3.6:  Oxygenation catalytic cycle 
Conditions chosen for the catalytic scheme included a 20 mol % loading of the 
catalyst, 2 eq. of a piperidinomethyl polystyrene resin base to assist cyclization and remove 
acid formed upon cyclization, 1 eq. of copper(II) triflate and nitromethane as the solvent 
under a pressure of 2 atm of oxygen.  Initial results with 6-endophenol substrate 3.6 were 
promising as product was being formed and starting material consumed.  However, upon 
isolation of the products, only a 64% of oxygenated material was recovered with the mass 
balance unaccounted for.  Attempts to cyclize the more challenging alkene terminating 
substrates 3.7 and 3.10 revealed a larger problem.  While a 43% yield of oxygenated material 
was recovered in the case of substrate 3.7, no conversion of product was observed with 
substrate 3.10.  While initially confounded by the complete lack of reactivity, analysis of the 
reaction mixture revealed formation of the Pt-alkyl complex, but no turnover (Figure 3.7).  A 
literature search revealed what was likely a redox incompatibility within the system.  
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Carpentier has reported that alkene containing compounds are able to reduce copper(II) 
triflate, producing unidentified organic products, triflic acid and copper(I) triflate as 
determined by ESR.
11
  The decomposition of the organic susbtrate explained the lack of mass 
balance recovered, the production of triflic acid explained the amount of Brønsted acid 
catalyzed products observed and the reduction of copper(II) triflate explained the lack of 
turnover observed with compound 3.9. 
Table 3.7:  Substrate scope 
 
Oxidant Screen 
The redox incompatibility of the above mentioned catalytic system led to exploration 
of alternative reagents and conditions to prevent substrate decomposition and allow for a 
more complete substrate scope.  We hypothesized that this could be achieved through several 
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different approaches, the use of milder oxidants or through the design of a new catalyst more 
susceptible to oxidation. 
To confirm this proposed redox incompatibility, several other oxidants were briefly 
explored.  Oxidants spanning a range of redox potentials were chosen, many of which 
provided visible indication of the oxidation as reduction of several oxidants resulted in 
dramatic color changes.  The oxidation potential of copper(II) triflate has been reported at 
0.40 V (vs Fc),
12
 at the high end of oxidants tested were [NO][BF4] (0.87 V vs Fc),
12
 
[Fe(bpy)3]
3+
 (0.70 V vs Fc) and [Fe(3,4,7,8-Me4phen)3]
3+
 (0.46 V vs Fc) (Table 3.8).   
Table 3.8:  Oxidant screen 
 
All of these oxidants were capable of rapidly oxidizing the Pt-alkyl, however, control 
reactions with only oxidant and substrate resulted in reduction of the oxidant (noted by color 
change in the Fe complexes).  At the low end of the oxidants was [N(tol)3][PF6], this oxidant 
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was capable of oxidizing the Pt-alkyl in acetonitrile, however, in contrast to reactions with 
Cu(OTf)2, this reaction was very slow.  Control reactions with substrate and [N(tol)3][PF6], 
resulted in slow reduction of the oxidant (noted by a loss color in solution).  That is, oxidants 
capable of oxidizing (triphos)Pt-R
+
 seem prone to reduction by substrate.  These results 
suggested that the redox incompatibility could not be overcome in the current catalytic 
manifold. 
Experimental Section 
All air and moisture sensitive procedures were performed using an MBraun glovebox or 
standard Schlenk line techniques.  Commercially available reagents were used without 
further purification.  The piperidinomethyl polystyrene resin (4.1 mmol/g) was purchased 
from NovaBiochem and used without further purification.  Acetonitrile was distilled from 
CaH2.  NMR spectra were collected on a Bruker 600 MHz Avance spectrometer and 
referenced to residual solvent peaks.  Reactions performed under elevated pressure were 
conducted in a Fisher Porter bottle.  Compounds 3.1,
13
 3.6,
13
 3.7
14
 and 3.10
15
 were prepared 
as previously reported.  HRMS was performed by Dr. Mee-Kyung Chung at the University of 
North Carolina at Chapel Hill except for compounds 3.5, 3.8 and 3.9 which were performed 
by the University of Illinois. 
General Procedure for Oxidation Reactions 
The oxidant of choice was added to a stirring solution of 3.1 (40 mg, 0.04 mmol) in CH3CN 
(3.0 mL).  Consumption of starting material was monitored by 
31
P NMR.  Compounds were 
isolated using preparative TLC or column chromatography (4:1 hexanes:EtOAc for 
oxygenated products; hexanes for halogenated products). 
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General Procedure for Catalytic Reactions 
To (PPP)PtI2 (40 mg, 0.04 mmol) was added AgBF4 (20 mg, 0.1 mmol) followed by 1.0 mL 
CD3NO2 in a 20 mL vial under N2 in the dark.  Simultaneously, Cu(OTf)2 (80 mg, 0.22 
mmol), piperidine resin base (95 mg, 0.4 mmol) and 1.0 mL CD3NO2 were added to a Fisher 
Porter bottle and pressurized to 2 atm O2.  Reactions were stirred for 1 hour at which time the 
solution of [(PPP)Pt][BF]2 previously prepared as above was syringe filtered through a 0.2 
µm PTFE syringe filter into the Fisher Porter containing Cu(OTf)2   and the piperidine resin 
base.  Substrate (0.2 mmol) was then added and the bottle re-pressurized to 2 atm O2.   
Following completion the crude material was loaded onto a large silica gel plug and eluted 
with diethyl ether.  Products were then isolated by column chromatography (4:1 
hexanes:EtOAc). 
Characterization of Compounds 
Compounds 3.2, 3.5ax and 3.5eq were formed in the same reaction, separated by prep TLC 
and characterized individually. 
Compound 3.2: 
 
1
H NMR (600 MHz, CDCl3):  δ 7.13 (m, 1H), 7.05 (m, 1H), 6.87 (m, 1H), 6.83 (m, 1H), 2.7 
(m, 1H), 2.60-2.45 (m, 4H), 2.25 (m, 2H), 2.05 (m, 2H), 1.38 (s, 3H) ppm.  
13
C NMR (152 
MHz, CDCl3) ): δ 208.8, 153.3, 129.5, 127.9, 120.5, 120.4, 117.5, 75.0, 44.5, 38.8, 38.7, 
38.0, 29.6, 16.1 ppm.  HRMS (ESI) C14H16O2 [M+H]
+
/z calc. 217.1223, found 217.1217. 
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Compound 3.5: 
 
3.5eq:  
1
H NMR (600 MHz, CDCl3):  δ 7.09 (m, 1H), 7.03 (m, 1H), 6.83 (m, 1H), 6.78 (m, 
1H), 3.80 (m, 1H), 2.60 (m, 1H), 2.51 (m, 1H), 2.03 (br, 2H), 1.97 (m, 1H), 1.88 (m, 1H), 
1.71 (m, 1H), 1.53 (m, 1H), 1.25 (m, 1H), 1.19 (s, 3H) ppm. 
13
C NMR (152 MHz, CDCl3): δ 
153.7, 129.6, 127.6, 121.6, 120.0, 117.4, 76.4, 70.2, 38.6, 37.6, 37.3, 32.6, 29.2, 16.7 ppm.   
HRMS C14H18O2 [M] calc. 218.1307, found 218.1299.  HRMS performed on mixture of 
3.5eq and 3.5ax. 
3.5ax:  
1
H NMR (600 MHz, CD2Cl2): δ 7.04 (m, 2H), 6.80 (m, 1H), 6.72 (m, 1H), 4.09 (br, 
1H), 2.51 (m, 1H), 2.44 (m, 1H), 2.25 (m, 1H), 2.00 (m, 1H), 1.83 (d, 2H), 1.71 (m, 2H), 
1.38 (m, 1H), 1.12 (s, 3H) ppm. 
13
C NMR (152 MHz, CD2Cl2): 154.1, 129.9, 127.6, 122.7, 
120.0, 117.4, 77.3, 65.9, 37.2, 33.5, 33.4, 30.8, 29.1, 15.9 ppm.   HRMS C14H18O2 [M] calc. 
218.1307, found 218.1299.  HRMS performed on mixture of 3.5eq and 3.5ax. 
Compound 3.3: 
 
3.3:  Diagnostic 
1
H NMR signals (600 MHz, CDCl3): δ 4.52 (br, 1H), 3.97 (m, 1H) ppm. 
HRMS (ESI) C14H17ClO [M+H]
+
/z calc. 237.1041, found 237.1043. 
Compound 3.4: 
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3.4:  Diagnostic 
1
H NMR signals (600 MHz, CDCl3): δ 4.73 (br, 1H), 4.11 (m, 1H)  ppm. 
HRMS (ESI) C14H17BrO [M+H]
+
/z calc. 281.0536, found 281.0536. 
Compounds 3.8, 3.9ax and 3.9eq were formed in the same reaction, separated by prep TLC 
and characterized individually. 
Compound 3.8: 
 
3.8:  
1
H NMR (600 MHz, CDCl3):  δ 7.40 (m, 2H), 7.34 (m, 2H), 7.27 (m, 1H), 6.07 (m, 1H), 
2.55 (m, 1H), 2.40-2.20 (m, 5H), 2.00-1.90 (m, 3H), 1.63-1.72 (m, 2H), 1.11 (s, 3H) ppm.  
13
C NMR (152 MHz, CDCl3) ): δ 211.4, 142.2, 135.6, 128.4, 127.0, 125.2, 122.4, 44.4, 43.0, 
40.7, 40.3, 38.4, 32.0, 31.2, 15.7 ppm.  HRMS (ESI) C17H20O [M] calc. 240.1514, found 
240.1506. 
Compound 3.9: 
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3.9eq:  
1
H NMR (600 MHz, CDCl3):  δ 7.38 (m, 2H), 7.32 (m, 2H), 7.24 (m, 1H), 6.05 (m, 
1H), 2.3-2.1 (m, 3H), 1.80-1.95 (m, 3H), 1.50-1.70 (m, 4H), 1.25-1.35 (m, 2H), 0.90 (s, 3H) 
ppm. 
13
C NMR (152 MHz, CDCl3): δ 142.7, 135.7, 128.3, 126.8, 125.2, 123.3, 71.3, 43.8, 
39.4, 38.1, 37.9, 31.9, 31.7, 30.8, 16.4 ppm.   HRMS C17H22O [M] calc. 242.1671, found 
242.1665.  HRMS performed on mixture of 3.9eq and 3.9ax. 
3.9ax:  
1
H NMR (600 MHz, CDCl3): δ 7.38 (m, 2H), 7.30 (m, 2H), 7.23 (m, 1H), 6.06 (br, 
1H), 4.05 (br, 1H), 2.29 (m, 1H), 2.05-2.17 (m ,2H), 1.94 (m, 1H), 1.79 (m, 2H), 1.69 (m, 
2H), 1.44 (m, 2H), 1.36 (m, 1H), 0.87 (s, 3H) ppm. 
13
C NMR (152 MHz, CDCl3): 142.9, 
135.6, 128.3, 126.7, 125.2, 123.6, 67.0, 44.2, 35.5, 34.6, 32.9, 32.5, 30.6, 29.0, 15.5 ppm.   
HRMS C17H22O [M] calc. 242.1671, found 242.1665.  HRMS performed on mixture of 3.9eq 
and 3.9ax. 
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CHAPTER 4:  POLYENE CYCLOISOMERIZATION REACTIONS
*
 
Introduction 
We have previously disclosed the cyclization of a variety of polyenes, including those 
terminating with nucleophilic heteroatoms as well as poorly nucleophilic alkenes.
1
  These 
methods have required highly electrophilic initiators to activate the substrate.  Successful 
systems have thus far been based on multidentate phosphine ligands, which are sufficiently 
electrophilic to initiate reactivity.   While stoichiometric reactions have been fruitful, the 
design of catalytic variants has proved challenging.  The remarkable stability of phosphine 
ligated platinum alkyl compounds toward both acid
2
 and oxidants has complicated the pursuit 
of catalysis.  Thus far, oxidation of intermediate Pt-alkyl compounds with XeF2
3
 or 
Cu(OTf)2
4
 has successfully turned over the catalyst, albeit with limited substrate scope.  
Bidentate phosphine ligands have enabled turnover through β-hydride elimination,5 however, 
these reactions require a complex mixture of reagents and produce multiple isomers of 
product in many cases.
5b
 
 Having been limited thus far by unfavorable redox properties of Pt phosphine 
complexes, alternative ligand frameworks were explored in an attempt to access new 
methods of turnover.  A catalyst with very specific properties was desired: highly 
electrophilic to initiate cyclization, yet sufficiently electron rich to allow for turnover through 
milder means.  We hypothesized that these two seemingly paradoxical properties could be 
                                               
*
 Portions of this chapter were adapted with permission from Geier, M.J.; Gagné, M.R. J. Am. Chem. Soc., 
2014, 136, 3032 
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realized by contrasting donor properties of the cis and trans positions.  In the cis position, 
highly donating ligands would provide the electron density required to ease oxidation while a 
poorly donating ligand in the trans position would maintain the electrophilic nature of the 
catalyst (Figure 4.1). 
 
Figure 4.1:  Desired ligand framework 
 A series of catalysts possessing these properties has been reported by Limbach for the 
hydrovinylation
6
 and hydroamination
7
 of simple olefins.  Several variants of the ligands were 
reported, however, all possess a poorly donating pyridine ligand in the trans position and two 
strongly donating NHC ligands in the cis positions.  These catalysts proved competent for the 
intermolecular hydrovinylation
6
 (Figure 4.2) and satisfied both our requirements and were 
thus explored in polyene cascade cyclization reactions. 
 
Figure 4.2:  Limbach’s Pt-catalyzed hydrovinylation 
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Initial Results 
Synthesis of (CNC)Pt catalyst 4.1 was first explored due to its high reactivity in both 
hydrovinylation and hydroamination reaction.   Previous difficulties in the 
protodemetallation of Pt-alkyls led to the expectation that this trend would hold for (CNC) 
ligands, as well as the previously reported phosphines.  Thus, initial reactions with two 
equivalents of 4.2 were run in presence of the piperidinomethyl polystyrene resin base used 
in previous experiments.  These reactions failed to produce any cyclized products.   
Interestingly, omission of the base led to full consumption of the substrate and yielded the 
fully cyclized product 4.3, resulting from protodemetallation of the Pt-alkyl.  Surprisingly, 
the intermediate Pt-alkyl complex proved sufficiently electron rich for the Pt-alkyl complex 
to be oxidized by the acid liberated by the cyclization (Figure 4.3). 
 
Figure 4.3:  Reaction of 4.1 with 4.2 
Any further attempts to trap the intermediate Pt-alkyl complex with base failed to 
cyclize, while attemps to trap the putative Pt-alkyl with any of the previously reported 
oxidants failed to produce the functionalized product.  Despite the inability to trap the 
organometallic, the catalyst proved very effective for the cycloisomerization reaction of 4.2.  
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At a catalyst loading of 10%, a 93% yield of product was obtained, while lowering the 
loading to 5% produced an 88% yield with reaction times of 2 and 3 hours respectively.  
Remarkably, the fully cyclized product was formed without formation of the Brønsted acid 
catalyzed product, previously observed with Pt-phosphine initiated reactions.  The absence of 
this product revealed a surprisingly low steady state concentration of acid despite the absence 
of base. 
 
Figure 4.4:  Polyene cycloisomerization mechanism 
The proposed catalytic cycle begins with selective coordination of the dicationic 
platinum catalyst to the least substituted alkene,
8
 subsequent cyclization forms the 
intermediate Pt-alkyl complex which undergoes rapid protodemetallation to form 4.3 and 
regenerate the Pt catalyst (Figure 4.4).  This reactivity observed with the nucleophilic phenol 
terminating group led to exploration of the cycloisomerization of alkene terminating 
substrates. 
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Alkene Terminating Substrates 
We began by investigating some simple bicyclization reactions involving previously 
reported substrates.
1b,5b
  In the presence of 10 mol % catalyst, these reactions were 
expectedly slower than the phenol terminating substrate.  Under these conditions, reaction 
with substrate 4.4 and 4.6 failed to consume starting material.  Despite the lack of reactivity 
noted with bases, the addition of diphenylamine as a proton shuttle led to shorter reaction 
times without poisoning the catalyst.  Optimization of the diphenylamine loading was done 
using substrate 4.4 and monitoring consumption of starting material by gc/ms (Table 4.1).  
This screen led to use of 20 mol % of diphenylamine which, not surprisingly, provided 
similar conversion to reactions employing stoichiometric amounts of diphenylamine. 
Table 4.1:  Optimization of proton shuttle loading 
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Table 4.2:  Substrate scope 
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 Several other bicyclization reactions proceeded in the absence of the diphenylamine 
proton shuttle.  Cyclization of substrate 4.8 resulted in formation of trisubstituted alkene 
containing 4.9.  Formation of the trisubstituted alkene as the kinetic product has been 
reported previously.
9
  The formation of this product was surprising as the absence of base in 
these reactions was expected to lead to isomerization to the tetrasubstituted alkene.  
Subsequent reaction of trisubstituted alkene 4.9 with methanesulfonic acid led to formation 
of the thermodynamically preferred tetrasubstituted alkene product 4.22 (Figure 4.6).  
 
Figure 4.5:  Isomerization of trisubstituted alkene to tetrasubstituted alkene 
Cyclization of aryl ether substrate 4.10 proceeded to give the rearranged product 4.11.  
This abnormal Claisen rearrangement has previously been observed by Yamomoto
10
 during 
Brønsted Lewis Acid mediated cyclizations.  While the mechanism for this rearrangement 
was not determined, two possibilities were considered.  Abnormal Claisen rearrangement to 
form the phenol followed by cyclization was favored (path A), however, A ring formation 
followed by phenoxy migration was not ruled out despite the involvement of a primary 
carbocation (path B) (Figure 4.5). 
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Figure 4.6:  Abnormal Claisen rearrangement of aryl ether 
 Tricyclization of several substrates with varying termination geometries was also 
explored.  6-endo terminating substrates 4.12 and 4.16 underwent cyclization to fully 
cyclized tetrasubstituted alkene containing 4.13 and 4.17.  In the case of 6-exo terminating 
substrate 4.14, two products were observed.  The major product was formed in 46% yield as 
a result of premature termination, forming a structure consistent with bicyclic compound 
4.23.  The minor product, formed in 23% yield was the fully cyclized compound 4.15, the 
result of tricyclization and elimination akin to 6-exo terminating substrate 4.6.   
In contrast to 6-endo and exo terminating substrates, 5-exo terminating substrates 
provided Wagner Meerwein rearranged products.  The major product came as a result of 
cyclization to the exocyclic cation followed by a hydride shift, a methyl shift and elimination 
to arrive at the tetrasubstituted alkene product 4.19 in a 39% isolated yield.  Elimination 
following the hydride shift resulted in formation of trisubstituted alkene product 4.24 in a 
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10% yield (Figure 4.7).  The two products could be separated from one another by Ag
+
 
impregnated silica gel.
11
 
 
Figure 4.7:  Rearrangement of substrate 4.16 
 The full cyclization of 5-exo terminating 4.18 led to exploration of the 
tetracyclization of compound 4.20, a substrate which, when fully cyclized would provide the 
6-6-6-5 steroid framework.  Cyclization of 4.20 proceeded slowly, taking several days to 
observe complete consumption.  Isolation of the major product revealed a tetracyclized 
product containing a tetrasubstituted alkene.  Initial cyclization of this substrate leads to an 
exocyclic cation, akin to the protosterol cation observed in the enzyme mediated formation of 
lanosterol.  In contrast to the skeletal rearrangement observed in nature in which the 
protosterol cation undergoes two methyl and two hydride shifts, the exocyclic cation 
undergoes only a hydride shift and a methyl shift, followed by elimination to produce 4.21, 
with unsaturation at the C/D ring junction (Figure 4.8).  
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Figure 4.8:  Wagner-Meerwein rearrangements of 4.20 and oxidosqualene 
Interestingly, while tetracyclization with 5-exo termination provided only fully 
cyclized products (determined by gc/ms), 6-exo terminating substrate 4.14 provided a 
mixture of bi and tricyclized products, suggesting a more concerted, efficient process in the 
case of 5-exo termination. 
 Use of nitromethane as solvent proved suitable in most cases, however, the slower tri 
and tetracyclization reactions saw shorter reaction which led to complete consumption of 
substrate in dichloromethane.  This increase in reactivity despite the tendency of the catalyst 
to abstract chloride from dichloromethane,
6
 is likely attributed to better substrate-solvent 
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miscibility in dichloromethane as well as previous studies which have revealed a shift in 
equilibrium toward cyclized product in more poorly solvating solvents.
12
 
 This catalytic system proved tolerant of a number of different substrates including a 
tetracyclization reaction.  While many of the more challenging tri and tetracyclization 
reactions proceeded to completion, lower yields were observed.  We have yet to identify the 
remainder of the mass balance, however, we suspect that formation of oligomeric species in 
the slower reactions may be responsible for the loss of mass balance.  
 The remarkable differences observed between phosphine based pincer complexes and 
those with NHC ligands in the cis position have enabled a novel cycloisomerization reaction 
involving several new, more complex alkene terminating substrates.  While uncertain of the 
cause for this change, the enhanced sigma donating ability of the NHC ligands may provide 
sufficient electron density at the Pt center to allow for protodemetallation.  This discovery 
has led to further exploration of this class of ligand, including the design of new chiral 
variants. 
 
Experimental Section 
General Considerations 
All air and moisture sensitive procedures were performed using an MBraun glovebox or 
standard Schlenk line techniques.  Commercially available reagents were used without 
further purification.  Deuterated nitromethane (CD3NO2) was degassed by freeze-pump-thaw.  
Dichloromethane, diethyl ether and toluene were passed through a column of alumina prior 
to use.  Diisopropylamine and triethylamine were distilled from calcium hydride.  NMR 
spectra were collected on a Bruker 600 or 400 MHz spectrometer and referenced to residual 
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solvent peaks.  HRMS was performed by University of Illinois except for compounds 4.10 
and 4.11, which were performed by Dr. Mee-Kyung Chung at the University of North 
Carolina at Chapel Hill.  Compounds 4.2,
1a
 4.3,
1a
 4.4,
5b
 4.6,
1b
 4.8,
1b
 4.12
1b
 and 4.18
1b
 have 
been reported previously. 
 
Substrate Synthesis 
New substrates 4.14, 4.16 and 4.20 were synthesized following established protocols for 
previously reported substrates, intermediates were characterized by 
1
H NMR and carried 
on.
1b
 
 
 
(E)-1,3-dimethoxy-5-((3-methylhepta-2,6-dien-1-yl)oxy)benzene (4.10):  Diethyl 
azodicarboxylate (DEAD) was added to a solution of (E)-3-methylhepta-2,6-dien-1-ol
13
 (0.63 
g, 5 mmol), 3,5-dimethoxyphenol (2.31 g, 15 mmol) and PPh3 (1.70 g, 6.5 mmol) in 25 mL 
THF.  The solution was brought to reflux for 2 hours.  Upon cooling, the solution was 
concentrated and purified by column chromatography using hexanes/EtOAc (19:1, Rf = 0.4) 
resulting in a yellow oil (0.72 g, 55% yield) 
1
H NMR (600 MHz, CDCl3):  δ 6.13 (m, 2H), 6.10 (m, 1H), 5.85-5.81 (m, 1H), 5.53-5.50 (m, 
1H), 5.03-5.07 (dd, 1H), 4.97-5.00 (dd, 1 H), 4.52 (d, J = 6.6 Hz, 2H), 3.79 (s, 6H) 2.24-2.18 
(m, 4H), 1.75 (s, 3H) ppm.  
13
C NMR (152 MHz, CDCl3): δ 161.7, 160.9, 140.9, 138.3, 
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119.8, 114.8, 93.7, 92.9, 64.9, 55.3, 38.9, 31.9, 16.6 ppm.  HRMS (ESI) C16H22O3 [M+H]
+
/z 
calc. 263.1642 found 263.1639. 
 
 
(E)-2,6,12-trimethyltrideca-1,6,11-trien-3-ol:  (E)-4,10-dimethylundeca-4,9-dienal
1b
 (4.03 g, 
20.7 mmol) was dissolved in 80 mL THF and cooled to -78˚C.  Isopropenyl magnesium 
bromide (50 mL, 0.5 M) was added slowly and the reaction was allowed to warm to room 
temperature overnight.  The reaction was quenched with saturated NH4Cl(aq) (60 mL) and 
separated.  The aqueous layer was extracted three times with diethyl ether.  The organics 
were combined and washed with water and brine before drying over Na2SO4.  Removal of 
volatiles produced a colourless oil (4.4 g, 18.6 mmol, 89%). 
1
H NMR (300 MHz, CDCl3):  δ 5.21-5.09 (m, 2H), 4.96 (s, 1H), 4.87 (s, 1H), 4.08-4.04 (m, 
1H), 2.07-1.97 (m, 5H), 1.74-1.56 (m, 16H), 1.40-1.32 (m, 2H) ppm. 
 
 
(4E,8E)-4,8,14-trimethylpentadeca-4,8,13-trienal:  (E)-2,6,12-trimethyltrideca-1,6,11-trien-3-
ol (4.49 g, 18.6 mmol) in ethyl vinyl ether (60 mL) was added to mercury trifluoroacetate 
(0.79 g, 1.86 mmol).  The reaction was stirred for 2 days at room temperature.  Ethyl vinyl 
ether was then removed under vacuum and the residue was passed through a silica gel plug in 
ethyl acetate.  Upon removal of ethyl acetate, 10 mL toluene was added and the solution was 
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heated to 130˚C in a pressure tube for 6 hours.  Removal of solvent left a colourless oil (4.2 
g, 16.0 mmol, 85%) 
1
H NMR (600 MHz, CDCl3):  δ 9.77 (s, 1H), 5.18-5.14 (m, 4H), 2.54-2.51 (m, 2H), 2.32-
2.35 (m, 2H), 2.12-1.97 (m, 7H), 1.70 (s, 3H), 1.66-1.61 (m, 9H) 1.38-1.32 (m, 2H)  ppm.   
 
 
(5E,9E)-5,9,15-trimethylhexadeca-1,5,9,14-tetraene (4.14):  To methyltriphenylphosphonium 
bromide (0.53 g, 1.48 mmol) in 6 mL THF was added nBuLi (0.6 mL, 2.5 M in hexane) at -
78˚C.  The reaction was stirred for 1 hour and a solution of (4E,8E)-4,8,14-
trimethylpentadeca-4,8,13-trienal (0.39 g, 1.48 mmol) in 6 mL THF was added.  The reaction 
was stirred and allowed to warm to room temperature overnight.  The reaction was quenched 
with 1 M HCl (15 mL).  The layers were separated and the aqueous extracted three times 
with diethyl ether.  The combined organics were washed with brine and dried over Na2SO4.  
Removal of volatiles and purification by silica gel (hexanes, Rf = 0.5) yielded the desired 
product as a colourless oil (0.18 g, 0.692 mmol, 47%) 
1
H NMR (600 MHz, CDCl3):  δ 5.85-5.80 (m, 1H), 5.16-5.13 (m, 3H), 5.04-5.01 (m, 1H), 
4.97-4.95 (m, 1H), 2.17-1.98 (m, 12H), 1.70 (s, 3H), 1.62-1.61 (m, 9H), 1.40-1.37 (m, 2H) 
ppm.  
13
C NMR (152 MHz, CDCl3): δ 138.8, 135.0, 134.4, 131.4, 124.8, 124.7, 124.6, 114.2, 
39.7, 39.1, 32.4, 30.1, 27.7, 27.6, 26.6, 25.8, 25.3, 17.8, 16.0 ppm.  HRMS (EI) C19H32 
[M]
+
/z calc. 260.2504 found 260.2508. 
 
 99 
 
 
(5E,9E)-11-bromo-5,9-dimethylundeca-1,5,9-triene:  A solution of (2E,6E)-3,7-
dimethylundeca-2,6,10-trien-1-ol
14
 (0.8 g, 4.1 mmol) in 15 mL THF was cooled to 0˚C.  
Methanesulfonyl chloride (0.5 mL, 6.46 mmol) and triethylamine (1.2 mL, 8.6 mmol) were 
added slowly and the reaction was stirred for 45 minutes at 0˚C.  A solution of lithium 
bromide (1.5 g, 17.2 mmol) in 5 mL THF was then added at 0˚C and the reaction stirred for 1 
hour at 0˚C.  Addition of 50 mL water and 50 mL hexanes formed a biphasic solution which 
was separated and the aqueous extracted three times with hexanes (3 x 50 mL).  The 
combined organics were washed with saturated NaHCO3(aq) and brine and dried over Na2SO4.  
Filtration and the removal of volatiles left a colourless oil (0.841 g, 3.3 mmol, 79%).   
1
H NMR (600 MHz, CDCl3):  δ 5.84-5.79 (m, 1H), 5.56-5.53 (m, 1H), 5.12-5.10 (m, 1H), 
5.04-5.00 (m, 1H), 4.96-4.94 (m, 1H), 4.04 (d, J = 8.4 Hz, 2H), 2.17-2.06 (m, 8 H)1.74 (s, 
3H), 1.62 (m, 3H) ppm.   
 
 
2-((2E,6E)-3,7-dimethylundeca-2,6,10-trien-1-yl)cyclohexan-1-one:  A solution of 
diisopropylamine (0.45 mL, 3.16 mmol) in 10 mL THF was cooled to -78˚C and n-BuLi (1.2 
mL, 2.5 M) was added slowly.  The reaction was stirred for one hour, at which time 
cyclohexanone (0.26 g, 2.64 mmol) was added.  The reaction was stirred for one hour and 
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(5E,9E)-11-bromo-5,9-dimethylundeca-1,5,9-triene (0.815 g, 3.16 mmol) was added at -78˚C 
and the reaction was left to warm to room temperature overnight.  The reaction was quenched 
with 1 M HCl (15 mL) and separated, the aqueous layer was extracted three times with 
diethyl ether and the combined organics were washed with brine and dried over Na2SO4.  
Removal of solvent under vacuum produced a colourless oil (0.63 g, 2.3 mmol, 87%).   
1
H NMR (600 MHz, CDCl3):  δ 5.87-5.78 (m, 1H), 5.12-5.10 (m, 2H), 5.04-5.01 (m, 1H), 
4.96-4.94 (m, 1H), 2.47-2.39 (m, 2H), 2.35-2.28 (m, 2H), 2.18-1.97 (m, 10H), 1.89-1.84 (m, 
1H), 1.72-1.66 (m, 2H), 1.61 (m, 6H), 1.40-1.34 (m, 2H) ppm.   
 
 
1-((2E,6E)-3,7-dimethylundeca-2,6,10-trien-1-yl)-2-methylenecyclohexane (4.16):  To a 
solution of 2-((2E,6E)-3,7-dimethylundeca-2,6,10-trien-1-yl)cyclohexan-1-one (0.2 g, 0.73 
mmol) in 25 mL diethyl ether was added  (trimethylsilyl)methylmagnesium chloride (1.46 
mL, 1.0 M).  The solution was heated to reflux for 18 hours at which time the reaction was 
cooled to 0˚C and thionyl chloride (0.22 mL, 3.03 mmol) was added.  The reaction was 
stirred for an hour and quenched with saturated NH4Cl(aq) (25 mL).  The layers were 
separated and the aqueous extracted twice with diethyl ether.  The combined organics were 
dried over Na2SO4.  Removal of volatiles produced a colourless oil which was purified by 
silica gel chromatography (hexanes, Rf = 0.6) to yield the product (0.107 g, 0.39 mmol, 
54%).  
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1
H NMR (600 MHz, CDCl3):  δ 5.85-5.80 (m, 1H), 5.17-5.13 (m, 2H), 5.03 (dd, J = 1.2, 16.8 
Hz, 1H), 4.95 (dd, J = 1.2, 10.2 Hz, 1H), 4.68 (m, 1H), 4.60 (m, 1H), 2.32-2.16 (m, 2H), 
2.17-2.02 (m, 12H), 1.78-1.83 (m, 1H), 1.72-1.68 (m, 2H), 1.63-1.61 (m, 6H), 1.45-1.44 (m, 
2H) ppm.  
13
C NMR (152 MHz, CDCl3): δ 153.3, 138.8, 135.4, 134.4, 124.6, 123.6, 114.2, 
105.2, 43.5, 39.8, 39.1, 35.6, 33.6, 32.4, 30.9, 28.9, 26.5, 25.0, 16.2, 16.0 ppm.  HRMS (EI) 
C20H32 [M]
+
/z calc. 272.2504 found 272.2507. 
 
 
(6E,10E)-2,6,10,15-tetramethylhexadeca-1,6,10,14-tetraen-3-ol:  (4E,8E)-4,8,13-
trimethyltetradeca-4,8,12-trienal
1b
 (2.20 g, 8.87 mmol) was dissolved in 25 mL THF and 
added slowly to the isopropenyl magnesium bromide (26.6 mL, 0.5 M) at -78˚C.  The 
reaction was stirred at room temperature for two hours.  The reaction was quenched with 
NH4Cl(aq) (60 mL) and separated.  The aqueous layer was extracted three times with diethyl 
ether.  The organics were combined and washed with water and brine before drying over 
Na2SO4.  Removal of volatiles produced a colourless oil (2.0 g, 6.89 mmol, 78%). 
1
H NMR (300 MHz, CDCl3):  δ 5.17-5.14 (m, 3H), 4.94 (s, 1H), 4.84 (s, 1H), 4.04 (m, 1H), 
2.08-1.99 (m, 11H), 1.74-1.55 (m, 17H) ppm. 
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(4E,8E,12E)-4,8,12,17-tetramethyloctadeca-4,8,12,16-tetraenal:  6E,10E)-2,6,10,15-
tetramethylhexadeca-1,6,10,14-tetraen-3-ol (2.0 g, 6.89 mmol) in ethyl vinyl ether (45 mL) 
was added to mercury trifluoroacetate (0.294 g, 0.69 mmol).  The reaction was stirred for 2 
days at room temperature.  Ethyl vinyl ether was then removed under vacuum and the residue 
was passed through a silica gel plug in ethyl acetate.  Upon removal of ethyl acetate, 40 mL 
toluene was added and the solution was heated to 130˚C in a pressure tube for 6 hours.  
Removal of solvent left a colourless oil.  Purification by column chromatography using 
hexanes/ethyl acetate (9:1) afforded the desired product (1.85 g, 5.85 mmol, 85%).  
1
H NMR (600 MHz, CDCl3):  δ 9.77 (s, 1H), 5.13-5.19 (m, 4H), 2.54-2.51 (m, 2H), 2.35-
2.33 (m, 2H), 2.12-1.98 (m, 12H), 1.71 (s, 3H), 1.65-1.62 (m, 12H) ppm.   
 
 
(5E,9E,13E)-5,9,13,18-tetramethylnonadeca-1,5,9,13,17-pentaene (4.20):  To 
methyltriphenylphosphonium bromide (1.22 g, 3.41 mmol) in 15 mL THF was added nBuLi 
(1.37 mL, 2.5 M in hexane) at -78˚C.  The reaction was stirred for 1 hour and a solution of 
(4E,8E,12E)-4,8,12,17-tetramethyloctadeca-4,8,12,16-tetraenal (0.900 g, 2.85 mmol)  in 10 
mL THF was added.  The reaction was stirred and allowed to warm to room temperature 
overnight.  The reaction was quenched with 1 M HCl (15 mL).  The layers were separated 
and the aqueous extracted three times with diethyl ether.  The combined organics were 
washed with brine and dried over Na2SO4.  Removal of volatiles and purification by silica gel 
(hexanes, Rf = 0.5) yielded the desired product as a colourless oil (0.6 g, 1.91 mmol, 67%). 
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1
H NMR (600 MHz, CDCl3):  δ 5.85-5.81 (m, 1H), 5.18-5.15 (m, 4H), 5.17-5.01 (dd, 1H), 
4.97-4.95 (dd, 1H), 2.19-2.03 (m, 16H), 1.72 (s, 3H), 1.63 (m, 12H)  ppm.  
13
C NMR (152 
MHz, CDCl3): δ 138.8, 135.2, 134.9, 134.4, 131.5, 124.6, 124.5, 124.4, 124.3, 114.2, 39.8, 
39.7, 39.1, 32.4, 28.4, 28.3, 26.64, 26.61, 25.8, 17.7, 16.04, 16.01, 15.97.  ppm.  HRMS (EI) 
C23H38 [M]
+
/z calc. 314.2974 found 314.2978. 
 
Standard Cyclization Procedure 
To (CNC)PtBr2 (0.015 mmol) was added solvent (1 mL) and AgBF4 (0.0375 mmol).  The 
mixture was stirred for 1 hour under N2 in the dark at which time AgBr was removed by 
syringe filter (0.45 µM PTFE) and substrate (0.15 mmol) was added to the solution.  Upon 
completion, the reaction was loaded directly onto a silica gel column and eluted with hexanes 
to yield the desired product.  Isolation of 4.19, 4.21 and 4.24 was performed using Ag
+
 
impregnated silica gel.
11
 
 
 
4.5:  
1
H NMR (400 MHz, CDCl3):  δ 7.41 (d, 2H), 7.33 (t, 2H), 7.26 (t, 1H), 6.07 (m, 1H), 
2.24-2.18 (m, 1H), 2.14-2.11 (m, 2H), 1.89-1.77 (m, 2H), 1.62-1.22 (m, 8H), 0.90 (s, 3H) .  
13
C NMR (101 MHz, CDCl3): δ 142.9, 135.5, 128.2, 126.5, 125.1, 123.7, 44.5, 41.5, 39.9, 
32.6, 31.0, 28.7, 26.9, 22.3, 16.3ppm.  HRMS (EI) C17H22 [M]
+
/z calc. 226.1722, found 
226.1725. 
 
 104 
 
 
4.7:  
1
H NMR (400 MHz, CDCl3):  δ 4.83 (m, 1H) 4.63 (m, 1H), 1.83-1.76 (m, 1H), 1.74 (s, 
3H), 1.72-1.68 (m, 2H), 1.55-1.48 (m, 2H), 1.44-1.36 (m, 3H), 1.28-1.21 (m, 7H), 1.08-1.00 
(m, 1H), 0.85 (s, 3H).  
13
C NMR (101 MHz, CDCl3): δ 147.9, 112.1, 56.8, 47.1, 40.0, 37.5, 
29.7, 29.1, 29.0, 28.1, 26.9, 24.5 22.1, 12.2 pm.  HRMS (EI) C14H24 [M]
+
/z calc. 192.1878, 
found 192.1877.  Compound 8 is volatile under high vac. 
 
 
4.9:  
1
H NMR (400 MHz, CDCl3):  δ 7.71 (d, J = 7.6 Hz, 1H), 7.16-7.11 (m, 3H), 6.45 (m, 
1H), 2.86-2.80 (m, 2H), 2.09-2.02 (m, 3H), 1.96-1.90 (m, 2H), 1.76 (m, 1H), 1.62 (m, 1H), 
1.50-1.41 (m, 4H), 1.31-1.26 (m, 2H), 1.13-1.05 (m, 1H) 0.79 (s, 3H) .  
13
C NMR (151 MHz, 
CD2Cl2): δ 136.8, 134.9, 133.7, 129.1, 126.1, 125.7, 123.0, 119.2, 49.6, 40.9, 38.4, 34.9, 
30.99, 30.98, 28.7, 26.5, 22.7, 22.3, 11.5 ppm.  HRMS (EI) C19H24 [M]
+
/z calc. 252.1878, 
found 252.1883.  
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4.11:  
1
H NMR (400 MHz, CDCl3):  δ 6.05 (s, 2H), 3.80 (s, 3H), 3.77 (s, 3H), 2.61-2.57 (dd, 
1H), 2.08-2.03 (m, 1H), 1.95-1.93 (m, 1H), 1.82-1.76 (m, 3H), 1.73-1.68 (m, 1H), 1.63-1.58 
(m, 1H), 1.52-1.45 (m, 1H), 1.39-1.32 (m, 1H), 1.21-1.13 (m, 1H), 1.17 (s, 3H).  
13
C NMR 
(101 MHz, CDCl3): δ 159.4, 158.3, 154.6, 103.6, 93.6, 90.8, 77.5, 55.4, 55.3, 39.4, 39.3, 
30.0, 26.0, 23.6, 23.5, 16.3 ppm.  HRMS (ESI) C16H22O3 [M+H]
+
/z calc. 263.1642, found 
263.1641.  
 
 
4.13:  
1
H NMR (400 MHz, CDCl3):  δ 5.37 (m, 1H), 2.05- 1.98 (m, 2H), 1.91-1.86 (m, 2H), 
1.71-1.61 (m, 3H), 1.58 (s, 3H), 1.56-1.10 (m, 11H), 0.89 (s, 3H), 0.81 (s, 3H) ppm. 
13
C 
NMR (101 MHz, CDCl3): δ 132.0, 120.3, 51.5, 51.1, 48.4, 42.3, 39.3, 36.4, 33.5, 28.7, 26.8, 
26.1, 23.8, 22.8, 21.6, 20.5, 12.6 ppm.  HRMS (EI) C17H28 [M]
+
/z calc. 232.2191, found 
232.2194.  
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4.15:  
1
H NMR (600 MHz, CDCl3):  δ 4.86 (m, 1H), 4.61 (m, 1H), 1.84-1.82 (m, 2H), 1.77 
(s, 3H), 1.71-1.57 (m, 4H), 1.52-1.43 (m, 2H), 1.37-1.14 (m, 7H), 1.09 (d, 1H), 1.05-0.98 (m, 
2H), 0.92-0.81 (m, 3H), 0.94 (s, 3H), 0.77 (s, 3H) .  
13
C NMR (162 MHz, CDCl3): δ 148.1, 
112.5, 58.8, 58.2, 48.5, 41.3, 39.5, 38.8, 37.0, 28.7, 28.4, 27.5, 26.8, 26.2, 25.7, 21.7, 20.7, 
14.7, 13.2 ppm.  HRMS (EI) C19H32 [M]
+
/z calc. 260.2504, found 260.2509.  
 
 
4.17:  
1
H NMR (600 MHz, CDCl3):  δ 1.87-1.76 (m, 7H), 1.71-1.65 (m, 4H), 1.57-1.53 (m, 
1H), 1.51- 1.45 (m, 4H), 1.44-1.36 (m, 2H), 1.30-1.14 (m, 7H), 1.18-1.12 (m, 1H), 0.87 (s, 
3H), 0.82 (s, 3H).  
13
C NMR (162 MHz, CDCl3): δ 126.8, 125.9, 52.0, 51.6, 48.4, 42.2, 39.3, 
36.4, 33.7, 30.4, 30.1, 28.8, 27.9, 26.8, 26.2, 23.30, 23.28, 21.6, 20.5, 12.5 ppm.  HRMS (EI) 
C20H32 [M]
+
/z calc. 272.2504, found 272.2501.  
 
 
 107 
 
4.19:  
1
H NMR (600 MHz, CDCl3):  δ 2.19-2.12 (m, 2H), 1.88-1.72 (m, 4H), 1.64-1.25 (m, 
12H), 0.97 (s, 3H), 0.89 (s, 3H), 0.85 (d, J = 6.6 Hz, 3H), 0.74 (d, J = 6.6 Hz, 3H) ppm.  
13
C 
NMR (162 MHz, CDCl3): δ 143.0, 137.8, 52.5, 44.3, 37.0, 35.2, 33.4, 30.2, 28.2, 28.1, 27.1, 
26.2, 25.3, 22.4, 21.9, 18.2, 17.6, 17.2 ppm.  HRMS (EI) C18H30 [M]
+
/z calc. 246.2348, 
found 246.2344.  
 
 
4.21:  
1
H NMR (600 MHz, CDCl3):  δ 2.21-2.17 (m, 1H), 2.12-2.08 (m, 1H), 1.98-1.93 (m, 
1H), 1.80-1.63 (m, 5H), 1.60 (sept., 1H), 1.54-1.04 (m, 14H) 0.98 (s, 3H), 0.96 (s, 3H), 0.85 
(d, J = 6.6 Hz, 3H), 0.79 (s, 3H), 0.74 (d, J = 6.6 Hz, 3H) ppm.  
13
C NMR (162 MHz, 
CDCl3): δ 144.0, 137.3, 55.1, 52.3, 48.6, 39.1, 38.2, 36.7, 36.5, 33.5, 30.2, 28.6, 27.7, 26.9, 
26.3, 25.4, 23.5, 21.6, 20.5, 18.2, 17.9, 17.7, 13.2 ppm.  HRMS (EI) C23H38 [M]
+
/z calc. 
314.2974, found 314.2969.  
 
Structural assignment of 4.21 was based upon the following NMR experiments.  The 
presence of only two sp
2 
carbons indicated the loss of four unsaturation equivalents and 
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formation of a tetracyclic product.  The absence of vinylic protons indicated the formation of 
a tetrasubstituted alkene.  Protons on diastereotopic methyl groups of C23 and C22 were 
identified by 
1
H NMR as the two upfield doublets.  From here, the isopropyl proton was 
identified based upon correlation to protons on C23 (blue arrow) and C22 (red arrow) in 
COSY and NOESY experiments.  Protons on C20 were then identified based upon 
correlation to the protons on C23 (green arrow) in NOESY and 1D Gradient NOESY 1 
experiments and correlation to the isopropyl proton (orange arrow) in 1D Gradient NOESY 
1.  The C13-C14 alkene was identified based upon HMBC correlation of C13 to the protons 
on C23 (purple arrow) and the isopropyl proton (grey arrow).  The protons on C18 were 
identified based upon HMBC correlation to C14 (cyan arrow).  The protons on C19 were 
identified based upon NOESY and 1D Gradient NOESY 2 correlation to the protons on C18 
(pink arrow). 
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1
H NMR (400 MHz, CDCl3):  δ 7.25 (m, 1H), 7.19 (m, 1H), 7.11 (m, 2H), 2.75-2.57 (m, 3H), 
2.39-2.28 (m, 2H), 2.23-2.11 (m, 1H), 1.91-1.86 (m, 1H), 1.79-1.75 (m, 1H), 1.67-1.53 (m, 
4H), 1.48-1.41 (m 3H), 1.33-1.25 (m 2H) 1.10 (s, 3H) .  
13
C NMR (101 MHz, CDCl3) : δ 
144.2, 137.3, 135.5, 126.7, 126.3, 125.7, 125.1, 121.9, 43.7, 38.0, 34.8, 29.2, 28.8, 27.0, 26.6, 
25.8, 22.9, 21.9, 18.1 ppm.  HRMS (EI) C19H24 [M]
+
/z calc. 252.1878, found 252.1882.  
 
 
1
H NMR (600 MHz, CDCl3):  δ 5.20 (m, 1H), 1.98-1.90 (m, 2H), 1.74-1.70 (m, 1H), 1.66-
1.50 (m, 6H), 1.45-1.40 (m, 2H), 1.38-1.31 (m, 1H), 1.28-1.18 (m, 4H), 1.11-1.06 (m, 1H), 
0.95 (s, 3H), 0.88 (d, J = 6.6 Hz, 3H), 0.83 (d, J = 6.6 Hz, 3H), 0.66 (s, 3H) ppm.  
13
C NMR 
(162 MHz, CDCl3): δ 150.8, 114.5, 56.4, 47.4, 41.6, 39.8, 36.2, 34.1, 33.3, 31.0, 28.6, 26.8, 
25.8, 22.8, 22.4, 18.1, 18.0, 11.6 ppm.  HRMS (ESI) C18H30 [M+H]
+
/z calc. 246.2348, found 
246.2352.  
 
As discussed in the text, a bicyclic byproduct was also formed in low yield.  Enough material 
was obtained to collect the following characterization data, which suggested that it might 
have the following structure (or others similar to it).  The presence of four sp
2
 carbons in the 
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13
C NMR was indicative of a bicyclic product.  The presence of the methyl doublet at 0.98 
ppm and the absence of a correlation between the two alkenes by HMBC suggested that the 
alkene isomerises away from the methyl group and away from the second alkene.  One 
structure that is consistent with these data and the presence of two vinylic protons is the 
following; there are no doubt others that are similarly consistent. 
 
1
H NMR (600 MHz, CDCl3):  δ 5.64 (m, 2H), 5.14 (m, 1H), 2.32-2.28 (m, 1H), 2.09-2.04 (m, 
1H), 1.96-1.93 (m, 2H), 1.86-1.79 (m, 1H), 1.71 (s, 3H), 1.62 (s, 3H), 1.57-1.51 (m, 2H), 
1.48-1.23 (m, 9H), 0.98 (d, J = 7.2 Hz, 3H), 0.90 (s, 3H), 0.86-0.77 (m, 1H). 
13
C NMR (162 
MHz, CDCl3): δ 133.2, 131.3, 126.1, 125.0, 42.1, 40.9, 37.8, 35.0, 33.6, 29.0, 28.8, 27.8, 
25.7, 24.5, 24.1, 22.0, 21.6, 17.8, 17.1 ppm.  HRMS (EI) C19H32 [M]
+
/z calc. 260.2504, 
found 260.2507.  
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CHAPTER 5:  SECONDARY CARBOCATION IN POLYCYCLIZATIONS 
Introduction 
The complex nature of polyene cyclizations has attracted attention from different 
areas.
1
  While there is a long history of biomimetic work
1b
 attempting to match the 
complexity observed in nature, recent advances in computational chemistry have generated 
significant interest in the nature of the cyclization itself.
1a
  Detailed analysis of these 
cyclization reactions has provided a complex and occasionally contradictory picture of the 
nature of the cyclizations.  While several reports have favored step-wise processes,
2
 recent 
work has generally confirmed the concerted, asynchronous formation of rings A,B and C in 
the formation of both lanosterol and hopene (Figure 5.1).
3
  These concerted, asynchronous 
reactions have no intermediates but involve a series of events that do not occur in concert
4
 
and are often encountered in formation of terpenoid natural products.
1a
  Though 
computational methods have provided significant insight, experimental study of such 
processes can be challenging.
5
 
 
Figure 5.1:  Concerted formation of rings A, B and C of hopene 
 Having executed the tetracyclization of substrate 5.1 (Figure 5.2), we turned our 
attention to experimental study of the nature of biomimetic polyene cyclization reactions.  
The synthesis of substrate 5.1 involved the step-wise construction of individual rings, 
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providing an opportunity for the design of a new family of substrates with selective 
modification, enabling experimental study of the nature of the cyclization. 
 
Figure 5.2: Tetracyclization of 5.1 
W.S. Johnson has reported a series of secondary alkene containing substrates
1c
 which 
proceed through secondary carbocations upon cyclization.  While comparison of vinyl and 
isopropenyl terminating groups resulted in cyclizations which struggled to engage the vinyl 
terminating group, direct comparison of substrates with selective placement of secondary 
alkenes throughout the cascade was not undertaken.
1c
  In a similar vein, E.J. Corey has 
reported the effect of replacement of the C-6 methyl group of 2,3-oxidosqualene with either a 
hydrogen or chloride (Figure 5.3), reducing the nucleophilicity of the alkene.  This study 
provided experimental evidence of the concerted nature of A ring formation in lanosterol 
through the effect of alkene nucleophilicty upon oxirane opening.
5
 
 
Figure 5.3:  2,3-oxidosqualene and analogs 
We proposed the synthesis of a series of substrates in which selective replacement of 
trisubstituted alkenes with secondary alkenes and comparison of their rates of cyclization 
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could provide an indication of the nature of the cyclization.  Through exploration of the 
effect of positioning of the secondary carbocation within the cascade, experimental insight 
into the concertedness and comparison of these biomimetic reactions to their biosynthetic 
counterparts could be gleaned. 
Substrates 
To design a series of substrates to probe the nature of the Pt-catalyzed polyene 
cyclization, we required the ability to systematically remove methyl groups in selected 
positions throughout the substrate.  The previously reported fully methylated substrate 5.1 
was synthesized through a sequence in which individual rings were formed through a three 
step sequence involving the addition of isopropenylmagnesium bromide to an aldehyde, a 
mercury trifluoroacetate catalyzed vinylation and a claisen rearrangement (Figure 5.4).
6
 
Figure 5.4:  Synthesis of 5.1 
We hypothesized that simple replacement of isopropenyl magnesium bromide with 
vinyl magnesium bromide would yield the desired secondary alkene.  While addition of the 
vinylmagnesium bromide and vinylation proceeded, this simple approach was unsuccessful, 
as the attempted Claisen rearrangement returned the vinyl ether to the alcohol (Figure 5.5).  
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Figure 5.5:  Attempted synthesis of secondary alkene 
To overcome the less favorable Claisen rearrangement, a literature search was 
performed and a new approach was undertaken.  Following a report by Wei,
7
 a one pot 
vinylation/Claisen rearrangement was explored using (1,10-phenanthroline)Pd(OAc)2 and 
triethyleneglycol divinylether.  This approach furnished a convenient route to the desired 
secondary alkenes (Figure 5.6).  With the ability to synthesize the necessary secondary and 
tertiary alkenes, a series of new substrates was prepared. 
 
Figure 5.6:  One pot vinylation/Claisen rearrangement 
 The synthesis of three new selectively demethylated substrates was achieved by 
selective placement of secondary alkenes throughout the cascade.  These three, in addition to 
our previously synthesized fully methylated substrate, formed the library of substrates for 
this study (Figure 5.7).  Naming of substrates was based upon the carbon at which the methyl 
group has been removed (ie. “5” for the substrate demethylated at C5). 
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Figure 5.7:  Library of penta-ene substrates 
Cyclization 
Cyclization of these new, secondary alkene containing substrates with (CNC)Pt
2+
 
proved, as expected, more challenging than their fully methylated counterpart.  Reaction 
times were significantly elongated and accompanied by the formation of multiple products in 
several cases.  Cyclization of the 9-demethylated substrate was performed, yielding the B/C 
demethylated analogue from the cyclization of fully methylated substrate 5.1 (Figure 5.8).  
Particularly noteworthy in the context of natural products, is the demethylated B/C ring 
junction, a structural motif that is characteristic to numerous natural sterols.
1d
  In contrast to 
cyclization with the fully methylated substrate which proceeded at 10% catalyst loading, in 
this case, catalyst loading was increased to 15% to compensate for catalyst deactivation over 
the extended reaction time (4 days).  Isolation of the desired product was achieved using Ag
+
 
impregnated silica gel
8
 in 54% yield.  The structure of 5.6 was determined by comparison to 
compound 5.2, providing a nearly identical spectrum, consistent with demethylation at the 
B/C ring junction. 
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Figure 5.8:  Cyclization of 5.4 
Cyclization of the 13-demethylated substrate provided a mixture of two fully cyclized 
compounds.  In contrast to the fully methylated substrate which rearranged to provide a 
tetrasubstituted alkene at the C/D ring junction, removal of the methyl group at C13 allowed 
for formation of a different tetrasubstituted alkene resulting from a single hydride shift and 
subsequent elimination.  With a catalyst loading of 15%, this tetrasubstituted alkene was 
preferred, forming in a 32% yield while the C/D unsaturated product formed as the minor 
product in 20% yield (Figure 5.9).  The two products were separated by Ag
+
 impregnated 
silica gel
8
 with 5.8 eluting first.  The structure of 5.8 was determined by comparison of 
1
H 
NMR with that of 5.2, providing a similar spectrum but lacking a methyl group.  Compound 
5.7 was characterized separately by 
1
H, 
13
C and selective 1D experiments (see supporting 
information). 
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Figure 5.9:  Cyclization of 5.3 
Cyclization of the 5-demethylated substrate proved significantly more challenging, 
forming several fully cyclized products as determined by fragmentation of the isopropyl 
group in the gc-ms spectra.  Attempts to run the reaction at a 15% or 30% catalyst loading 
resulted in catalyst deactivation prior to full consumption of substrate.  Increasing the catalyst 
loading to 50% resulted in a reaction time of approximately 4 days with full consumption of 
starting material.  While the expected C/D unsaturated tetracycle was formed as the major 
product as observed by gc-ms, isolation proved challenging.  Separation was achieved after 
multiple Ag
+
 impregnated silica gel columns, resulting in an 18% isolated yield (Figure 
5.10).  The structure of 5.9 was determined by comparison of the 
1
H NMR with that of 5.2.  
While several other fully cyclized minor products were observed by gc-ms, they proved 
inseparable despite multiple attempts at isolation. 
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Figure 5.10:  Cyclization of 5.5 
Competition Experiments 
While standard cyclization reactions provided an indication of relative rates of 
cyclization of the demethylated substrates, particularly the slow cyclization of 5.5, 
competition experiments were performed so that more accurate measures of the methyl 
deletion experiments could be achieved.  Monitoring the product/s.m. evolution over time by 
gc-ms proved particularly useful.  While enzyme mediated cyclizations often proceed 
through a concerted, asynchronous mechanism, considering the effect of both stepwise and 
concerted reactions upon the relative rates of cyclization of the demethylated substrates 
proved helpful. 
 
Figure 5.11:  Relative rates for concerted, synchronous cyclization  
In the case of a concerted, synchronous pathway in which no intermediates exist and 
all bonds are formed and broken simultaneously, the rates of cyclization of the three 
demethylated substrates should be very similar, but slower than the rate of cyclization of the 
fully methylated substrate (Figure 5.11).  In this case, the positioning of the secondary alkene 
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is irrelevant, as all bonds are formed and broken in a single transition state.  A reaction 
coordinate diagram for the concerted cyclizations can be envisioned.  As is the case for 
concerted reactions, there are no intermediates or minima on the reaction coordinate and a 
single transition structure in which all bonds are formed and broken.  In the case of a fully 
concerted, synchronous reaction, cyclization of “5”, “9” and “13” proceed through transition 
states of equal energy (Figure 5.12), with the transition structure of “0” being lower in 
energy. 
 
 
Figure 5.12:  Reaction coordinate for a concerted, synchronous reaction  
A step wise mechanism in which A-ring formation is rate limiting and occurs without 
interaction from the forming B and C rings was expected to provide a significantly different 
picture.  In this case, cyclization of the 5-demethylated substrate was expected to be slowest 
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due to formation of the secondary carbocation generated upon formation of the A ring.  The 
three remaining substrates were anticipated to provide similar rates, due to the identical 
nature of their A-ring formation (Figure 5.12). 
 
Figure 5.13:  Relative rates for step-wise cyclization 
Substrates were paired for competition experiments, with 1 equivalent of each 
substrate and 1 equivalent of catalyst in dichloromethane.  Reactions were checked hourly by 
gc-ms and relative rates determined by relative product formation.  Pairing of the fully 
methylated substrate and the 9-demethylated substrate revealed a relative rate (k0/k9) of 4.5.  
Pairing of the 9-demethylated and 13-demethylated substrate provided a relative rate (k13/k9) 
of 2.2.  Significant changes in rate were observed in pairings with the 5-demethylated 
substrate, with the 9-demethylated substrate a relative rate of (k9/k5) of 10 was observed, 
while pairing with 13-demethylated substrate produced a relative rate (k13/k5) of 14. 
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Discussion 
Taken together, these competition experiments paint a picture of a complex 
cyclization procedure.  While a strictly concerted or strictly stepwise process can be ruled 
out, a combination of the two appears to be operative.  These results suggest a concerted, yet 
highly asynchronous reaction appears to fit the data.
4
  
 Concerted processes have been invoked in several cases to avoid the intermediacy of 
high energy secondary carbocations.  Hess first proposed a concerted C ring expansion and D 
ring formation in the formation of lanosterol, avoiding a secondary carbocation 
intermediate.
9
  More recently, Tantillo has proposed concerted mechanisms to avoid similar 
high energy intermediates.
10
  The relative rate data obtained, suggesting a concerted 
mechanism, indicating secondary carbocations may be avoided in similar fashion in these 
biomimetic reactions. 
The involvement of concerted, asynchronous reactions have also been proposed by 
Hess in the formation of hopene and lanosterol.  Computational study revealed concerted, yet 
highly asynchronous formation of the A, B and C rings (with initial formation of a 5-
membered C-ring) of both hopene
3a
 and lanosterol.
3b
  These processes were characterized by 
nearly full closure of the A ring prior to significant involvement from the forming B and C 
rings.  
The significantly slower cyclization of the 5-demethylated substrate is consistent with 
rate limiting A ring formation, where full A ring closure is likely to occur without significant 
assistance from the forming B and C rings.  The differences observed between the 
demethylated substrates 5.3, 5.4, 5.5 and the fully methylated substrate 5.1 suggest a 
concerted process, in which participation of the forming B, C and D rings are involved.  
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Relative rates increase as the secondary carbocation is farther removed from the A ring, 
suggesting progressively less involvement from rings B, C and D. 
A reaction coordinate diagram similar to that for the strictly concerted reaction 
(Figure 5.12) can be envisioned with several key differences.  In the case of a concerted 
asynchronous reaction, the transition structure for the cyclization of all substrates is different.  
Cyclization of “0” being the lowest in energy, followed by “13”, then “9” then “5”.  Given 
the significantly slower cyclization, a transition structure in which nearly full formation of 
the A ring is observed without significant stabilization from the forming B and C rings can be 
expected.  This transition structure, resembling A ring formation in which the carbocation in 
the A ring bears the majority of the developing positive charge, results in a significant gap in 
the relative energy between the transition structure in the cyclization of “5” and the others 
(Figure 5.14) as a result of the secondary carbocation involved in A ring formation in the 
cyclization of “5”. 
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Figure 5.14:  Reaction coordinate diagram from concerted, asynchronous reaction 
Interestingly, the concerted but highly asynchronous reactivity of this biomimetic 
reaction draws significant parallels to the formation of the A, B and C rings in the enzyme 
mediated formation of hopene and lanosterol.  While the exact role of the enzyme has been 
debated, with some suggesting a role in carbocation stabilization while others have proposed 
the enzyme functions as a protector, preventing carbocation quenching.
1b
  The similarities 
between the biological and these biomimetic reactions suggest at least in part, a limited role 
for the enzyme in determination of the nature of the cyclization.  
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Experimental Section 
General Considerations 
All air and moisture sensitive procedures were performed using an MBraun glovebox or 
standard Schlenk line techniques.  Commercially available reagents were used without 
further purification.  Dichloromethane and toluene were passed through a column of alumina 
prior to use.  NMR spectra were collected on a Bruker 600 or 400 MHz spectrometer and 
referenced to residual solvent peaks.  HRMS was performed by Dr. Mee-Kyung Chung at the 
University of North Carolina at Chapel Hill.  Compounds 5.1 and 5.2 have been reported 
previously. 
Competition Experiments 
(CNC)PtBr2 (0.017 mmol), dichloromethane (0.4 mL) and AgBF4 (0.00625 mmol) were 
added together and the mixture was stirred for 1 hour under N2 in the dark.  AgBr was then 
removed by syringe filter (0.45 µM PTFE) and substrates (0.017 mmol of each) were added 
to the solution.  The reactions were monitored by taking aliquots and analyzed by gc-ms.  
Relative rates were obtained by measuring though integration the relative amount of product 
by gc/ms. 
Substrate Synthesis 
All substrates were prepared following established protocols for previously reported 
substrates.
6-7
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(E)-6,11-dimethyldodeca-1,6,10-trien-3-ol:  Vinylmagnesium bromide (8.3 mL, 1.0 M in 
THF) was cooled to -78˚C and (E)-4,9-dimethyldeca-4,8-dienal11 (1.0 g, 5.55 mmol) was 
added in 5 mL of THF.  The reaction was left to warm overnight with stirring.  The reaction 
was then quenched with a saturated solution of ammonium chloride, the layers were 
separated and the aqueous layer was washed three times with diethyl ether.  The combined 
organics were washed with brine and dried over magnesium sulfate.  Removal of solvent 
produced the desired product (0.90 g, 4.33 mmol, 78% yield) which was carried on without 
further purification. 
1
H NMR (600 MHz, CDCl3):  δ 5.92-5.86 (m, 1H), 5.26-5.23 (d, 1H), 5.20 (m, 1H), 5.15-
5.12 (m, 2H), 4.12 (m, 1H), 2.11-2.02 (m, 6H), 1.71 (s, 3H), 1.67-1.62 (m, 2H), 1.63 (s, 3H), 
1.62 (s, 3H) ppm.  
13
C NMR (152 MHz, CDCl3): δ 141.1, 134.8, 131.6, 124.9, 124.3, 114.6, 
73.0, 35.5, 35.1, 28.3, 28.2, 25.7, 17.7, 16.0 ppm.   
 
 
(4E,8E)-8,13-dimethyltetradeca-4,8,12-trienal: Procedure adapted from Wei et al.
7
  (E)-6,11-
dimethyldodeca-1,6,10-trien-3-ol (0.90 g, 4.33 mmol), tri(ethylene glycol) divinyl ether 
(TGDV) (1.31 g, 6.48 mmol) and (1,10-phenanthroline)Pd(OAc)2 (0.009 g, 0.02 mmol) were 
combined in a roundbottom flask equipped with a reflux condenser open to air.  The reaction 
was heated at 70˚C for two days followed by 110˚C for four hours.  The crude mixture was 
then purified by silica gel column chromatography (10:1 hexanes : ethyl acetate, Rf = 0.5) to 
yield the desired product (0.83 g, 3.55 mmol, 82% yield). 
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1
H NMR (600 MHz, CDCl3):  δ 9.77 (m, 1H), 5.48-5.43 (m, 2H), 5.14 (m, 2H), 2.51-.249 (m, 
2H), 2.36-2.33 (m, 2H), 2.10-2.07 (m, 2H), 2.02-2.00 (m, 6H), 1.70 (s, 3H), 1.62 (s, 3H), 
1.60 (s, 3H) ppm.  
13
C NMR (152 MHz, CDCl3): δ 202.4, 134.6, 131.7, 131.5, 127.7, 124.6, 
124.4, 43.5, 39.5, 31.0, 28.3, 28.2, 25.7, 25.2, 17.7, 16.0 ppm.   
 
 
(6E,10E)-2,10,15-trimethylhexadeca-1,6,10,14-tetraen-3-ol:  Isopropenylmagnesium 
bromide (10.6 mL, 0.5 M in THF) was cooled to -78˚C and (4E,8E)-8,13-dimethyltetradeca-
4,8,12-trienal (0.83 g, 3.55 mmol) was added with 5 mL THF.  The reaction was left to warm 
overnight with stirring.  The reaction was quenched with a saturated solution of ammonium 
chloride and the aqueous layer was washed three times with diethyl ether.  The combined 
organic layers were washed with brine and dried over sodium sulfate.  Removal of solvent 
yielded the desired product (0.50 g, 1.81 mmol, 52% yield) 
1
H NMR (600 MHz, CDCl3):  δ 5.46-5.44 (m, 2H), 5.16-5.15 (m, 2H), 4.96 (m, 1H), 4.85 (m, 
1H), 4.09 (m, 1H), 2.11-2.02 (m, 12H), 1.74 (s, 3H), 1.71 (s, 3H), 1.64 (s, 3H), 1.63 (s, 3H) 
ppm.  
13
C NMR (152 MHz, CDCl3): δ 147.5, 134.8, 131.5, 130.8, 129.6, 124.5, 124.4, 111.0, 
75.4, 39.7, 34.7, 31.2, 28.8, 28.4, 28.2, 25.7, 17.7, 17.6, 16.0 ppm.   
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(4E,8E,12E)-4,12,17-trimethyloctadeca-4,8,12,16-tetraenal: (6E,10E)-2,10,15-
trimethylhexadeca-1,6,10,14-tetraen-3-ol (0.50 g, 1.81 mmol), ethyl vinyl ether (15 mL) and 
mercury trifluoroacetate (0.08 g, 0.18 mmol) were stirred for 24 hours at room temperature.  
The ethyl vinyl ether was removed under reduced pressure and the residue loaded onto a 
silica gel plug and eluted with ethyl acetate to remove the mercury trifluoroacate.  The 
solvent was removed and the oil was dissolved in 8 mL of toluene and heated to 120˚C for 
six hours.  The toluene was removed and the residue purified by silica gel column 
chromatography (9:1 hexanes : ethyl acetate, Rf = 0.5) to produce the desired product (0.27 g, 
0.89 mmol, 49% yield). 
1
H NMR (400 MHz, CDCl3):  δ 9.76 (m, 1H), 5.42-5.40 (m, 2H), 5.17-5.14 (m, 3H), 2.52-
2.50 (m, 2H), 2.35-2.33 (m, 2H), 2.07-2.01 (m, 12H), 1.70 (s, 3H), 1.61-1.60, (m, 9H) ppm.  
13
C NMR (101 MHz, CDCl3): δ 202.6, 134.8, 133.1, 131.4, 130.4, 129.7, 125.2, 124.44, 
124.40, 42.2, 39.8, 32.6, 31.9, 31.2, 28.4, 28.2, 28.1, 25.7, 17.7, 16.1, 16.0 ppm.   
 
 
5.4: (5E,9E,13E)-5,13,18-trimethylnonadeca-1,5,9,13,17-pentaene: To a solution of 
triphenylphosphonium bromide (0.383 g, 1.07 mmol) in THF (5 mL) at -78˚C, was added n-
BuLi (0.65 mL, 1.6 M in THF), the solution was then stirred for 1 hour at -78˚C. 
(4E,8E,12E)-4,12,17-trimethyloctadeca-4,8,12,16-tetraenal (0.27 g, 0.89 mmol) in THF (3 
mL) was then added and the reaction was allowed to warm to room temperature overnight.  
The reaction was quenched with a saturated solution of ammonium chloride and the layers 
 136 
 
were separated.  The aqueous layer was washed three times with diethyl ether and the 
combined organics washed with brine and dried over sodium sulfate.  Removal of solvent 
and purification by silica gel column chromatography (hexanes, Rf = 0.6) yielded the product 
(0.085 g, 0.28 mmol, 32% yield) 
1
H NMR (600 MHz, CDCl3):  δ 5.86-5.81 (m, 1H), 5.45-5.43 (m, 2H), 5.18-5.16 (m, 3H), 
5.05-5.02 (m, 1H), 4.97-4.96 (m, 1H), 2.19-2.03 (m, 16H), 1.72 (s, 3H), 1.64-1.62 (m, 9H) 
ppm.  
13
C NMR (152 MHz, CDCl3): δ 138.8, 134.9, 134.6, 131.4, 130.2, 130.0, 124.5, 
124.40, 124.39, 114.2, 39.8, 39.1, 32.8, 32.4, 31.3, 28.4, 28.2, 28.1, 25.7, 17.7, 16.03, 16.01 
ppm.  HRMS (EI) C22H36 [M]
+
/z calc. 301.2890 found 301.2893. 
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(E)-2,11-dimethyldodeca-1,6,10-trien-3-ol:  Isopropenylmagnesium bromide (10.85 mL, 
0.5M in THF) was cooled to -78˚C, at which time, (E)-9-methyldeca-4,8-dienal7 (0.6 g, 3.6 
mmol) was added via 15 mL THF.  The -78˚C bath was removed and the reaction was stirred 
for two hours.  The reaction was quenched with a saturated ammonium chloride solution, the 
layers were separated and the aqueous layer was washed twice with diethyl ether.  The 
combined organics were washed with brined and dried with sodium sulfate.  The solvent was 
removed and the residue purified by flash column chromatography (5:1 hexanes:ethyl 
acetate, Rf = 0.5) to yield a colourless oil (0.610 g, 2.9 mmol, 82% yield). 
1
H NMR (600 MHz, CDCl3):  δ 5.46-5.44 (m, 2H), 5.13-5.11 (m, 1H), 4.95 (s, 1H), 4.84 (s, 
1H), 4.09-4.07 (m, 1H),  2.05-2.03 (m, 8H), 1.73 (s, 3H), 1.70 (s, 3H), 1.62 (s, 3H) ppm.  
13
C 
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NMR (152 MHz, CDCl3): δ 147.5, 131.6, 130.7, 129.7, 124.1, 111.0, 75.4, 34.7, 32.8, 28.7, 
28.1, 25.7, 17.7, 17.6 ppm.   
 
 
(4E,8E)-4,13-dimethyltetradeca-4,8,12-trienal:  (E)-2,11-dimethyldodeca-1,6,10-trien-3-ol 
(0.61 g, 2.9 mmol) was dissolved in 10 mL of ethyl vinyl ether.  Mercury trifluoroacetate 
(0.125 g, 0.29 mmol) was then added and the reaction was stirred for 2 days.  Ethyl vinyl 
ether was then removed under vacuum and the mercury trifluoroacetate was removed by 
passing the residue through a silica gel plug in ethyl acetate.  The ethyl acetate was then 
removed and the oil was dissolved in 10 mL of toluene and heated to 120˚C in a pressure 
tube for 6 hours.  The toluene was removed and the compound was purified by column 
chromatography (9:1 hexanes:ethyl acetate, Rf = 0.6) to yield a colourless oil (0.53 g, 0.23 
mmol, 77% yield).  
1
H NMR (600 MHz, CDCl3):  δ 9.76 (m, 1H), 5.43-5.0 (m, 2H), 5.18 (m, 1H), 5.12 (m, 1H), 
2.53-2.50 (m, 2H), 2.34-2.32 (m 2H), 2.04-2.02 (m, 8H), 1.69 (s, 3H), 1.62 (s, 3H), 1.61 (s, 
3H) ppm.  
13
C NMR (152 MHz, CDCl3): δ 202.6, 133.1, 131.5, 130.4, 129.8, 125.2, 124.2, 
42.2, 32.8, 32.6, 31.9, 28.1, 28.0, 25.7, 17.7, 16.1 ppm.   
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(6E,10E)-2,6,15-trimethylhexadeca-1,6,10,14-tetraen-3-ol:  A solution of 
isopropenylmagnseium bromide (4.2 mL, 0.5 M in THF) was cooled to -78˚C.  (4E,8E)-4,13-
dimethyltetradeca-4,8,12-trienal (0.33 g, 1.41 mmol) was then added with 3 mL THF.  The 
dry ice/acetone bath was removed and the reaction was stirred for 2 hours while warming.  
The reaction was quenched with a saturated ammonium chloride solution and the layers were 
separated.  The aqueous layer was extracted three times with diethyl ether.  The combined 
organics were washed with brine and dried over sodium sulphate.  Removal of solvent 
produced the desired compound (0.315 g, 1.15 mmol, 82% yield) 
1
H NMR (600 MHz, CDCl3):  δ 5.43 (m, 2H), 5.18-5.17 (m, 1H), 5.13-5.12 (m, 1H), 4.95-
4.94 (m, 1H), 4.84 (m, 1H) 4.06-4.02 (m, 1H), 2.03-1.96 (m, 12H), 1.73 (s, 3H), 1.70 (s, 3H), 
1.68-1.65 (m, 6H) ppm.  
13
C NMR (152 MHz, CDCl3): δ 147.5, 134.9, 131.5, 130.3, 130.0, 
124.5, 124.2, 111.0, 75.6, 35.7, 33.2, 32.84, 32.78, 28.2, 28.1, 25.7, 17.7, 17.6, 16.0 ppm.   
 
 
(4E,8E,12E)-4,8,17-trimethyloctadeca-4,8,12,16-tetraenal:  (6E,10E)-2,6,15-
trimethylhexadeca-1,6,10,14-tetraen-3-ol (0.315 g, 1.15 mmol), mercury trifluoroacetate 
(0.049 g, 1.15 mmol) and ethyl vinyl ether (10 mL) were stirred for two days at room 
temperature.  The ethyl vinyl ether was removed under reduced pressure and the mercury 
removed by loading the residue on a silica gel plug and eluting with ethyl acetate.  The ethyl 
acetate was removed, the oil dissolved in toluene (10 mL) and heated at 120˚C for six hours.  
The solvent was removed to produce the desired product (0.30 g, 0.99 mmol, 86% yield) 
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1
H NMR (600 MHz, CDCl3):  δ 9.76 (m, 1H), 5.44 (m, 2H), 5.16-5.14 (m, 3H), 2.53-2.50 (m, 
2H), 2.35-2.32 (m, 2H), 2.11-2.00 (m, 12 H), 1.71 (s, 3H), 1.63-1.62 (m, 9H) ppm.  
13
C NMR 
(152 MHz, CDCl3): δ 202.7, 134.8, 132.9, 131.5, 130.2, 130.1, 125.4, 124.3, 124.2, 42.2, 
39.5, 32.9, 32.8, 31.9, 28.2, 28.1, 26.5, 25.7, 17.7, 16.1, 16.0 ppm.   
 
 
5.3: (5E,9E,13E)-5,9,18-trimethylnonadeca-1,5,9,13,17-pentaene:  To triphenylphosphonium 
bromide (0.43 g, 1.19 mmol) in THF (5 mL) at -78˚C, was added n-BuLi (0.47 mL, 1.6 M in 
THF).  The mixture was stirred for 1 hour at -78˚C and (4E,8E,12E)-4,8,17-
trimethyloctadeca-4,8,12,16-tetraenal (0.3 g, 0.99 mmol) was added via 4 mL THF.  The 
reaction was left to warm overnight while stirring.  The reaction was quenched with a 
saturated solution of ammonium chloride.  The layers were separated and the aqueous 
extracted three times with diethyl ether.  The combined organics were washed with brine and 
dried over sodium sulphate.  Removal of solvent and purification by silica gel column 
chromatography (hexanes, Rf = 0.6) furnished the desired product (0.053 g, 0.18 mmol, 13% 
yield). 
 
1
H NMR (600 MHz, CDCl3):  δ 5.86-5.81 (m, 1H), 5.46 (m, 2H), 5.18-5.14 (m, 3H), 5.05-
5.02 (m, 1H), 4.97-4.95 (m, 1H), 2.18-2.01 (m, 16H), 1.72 (s, 3H), 1.64-1.63 (m, 9H) ppm.  
13
C NMR (152 MHz, CDCl3): δ 138.8, 135.1, 134.4, 131.5, 130.2 (X2), 124.6, 124.2, 124.1, 
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114.2, 39.7, 39.1, 32.9, 32.4, 28.3, 28.1, 26.7, 26.5, 25.7, 17.8, 16.1, 16.0.  HRMS (EI) 
C22H36 [M]
+
/z calc. 301.2895 found 301.2893.
 
 
 142 
 
 
(6E,10E)-6,10,15-trimethylhexadeca-1,6,10,14-tetraen-3-ol:  A solution of vinylmagnesium 
bromide (4.8 mL, 1.0M in THF) was cooled to -78˚C.  (4E,8E)-4,8,13-trimethyltetradeca-
4,8,12-trienal
11
 (0.8 g, 3.23 mmol) was then added via 5 mL THF and the -78˚C bath was 
removed.  The reaction was stirred for 2 hours, at which time the reaction was quenched with 
a saturated solution of ammonium chloride.  The layers were separated and the aqueous 
extracted three times with diethyl ether.  The combined organics were extracted with brine 
and dried over sodium sulphate.  Removal of solvent produced the desired product which 
was carried on without further purification (0.7 g, 2.5 mmol, 78% yield). 
1
H NMR (600 MHz, CDCl3):  δ 5.88 (m, 1H), 5.22 (dd, 1H), 5.17-5.13 (m, 3H), 5.09 (dd, 
1H), 4.08 (m, 1H), 2.11-1.98 (m, 12H), 1.68 (s, 3H), 1.61 (s, 9H) ppm.  
13
C NMR (152 MHz, 
CDCl3): δ 141.2, 135.0, 134.6, 131.4, 124.8, 124.41, 124.4, 114.5, 72.8, 39.6, 35.5, 35.2, 
28.3, 28.2, 26.6, 25.7, 17.7, 16.0, 15.9 ppm.   
 
 
(4E,8E,12E)-8,12,17-trimethyloctadeca-4,8,12,16-tetraenal:  Procedure adapted from Wei et 
al.
7
 (6E,10E)-6,10,15-trimethylhexadeca-1,6,10,14-tetraen-3-ol (0.7 g, 2.5 mmol), 
tri(ethylene glycol) divinyl ether (TGDV) (0.76 g, 3.76 mmol) and (1,10-
phenanthroline)Pd(OAc)2 (0.006 g, 0.015 mmol) were added to roundbottom flask equipped 
 143 
 
with a condenser open to air.  The reaction was heated to 75˚C for two days followed by 4 
hours at 110˚C.  The residue was purified by silica gel column chromatography (15:1 
hexanes: ethyl acetate) to yield the desired product (0.4 g, 1.32 mmol, 53% yield). 
1
H NMR (600 MHz, CDCl3):  δ 9.77 (m, 1H), 5.48-5.39 (m, 2H), 5.16-5.09 (m, 3H), 2.49-
2.48 (m,2H), 2.34-2.33 (m,2H), 2.10-1.99 (m, 12H), 1.69 (s, 3H), 1.61 (s, 9H)  ppm.  
13
C 
NMR (152 MHz, CDCl3): δ 202.3, 135.1, 134.4, 133.9, 131.7, 127.7, 124.6, 124.5, 124.3, 
39.7, 39.5, 31.1, 28.4, 28.33, 28.25, 26.6, 25.7, 25.2, 17.7, 16.01, 15.96 ppm.   
 
 
5.5:  (5E,9E,13E)-9,13,18-trimethylnonadeca-1,5,9,13,17-pentaene: To a solution of 
triphenylphosphonium bromide (0.62 g, 1.74 mmol) in THF (6 mL) at -78˚C, was added n-
BuLi (1.05 mL, 1.6 M in THF), the solution was then stirred for 1 hour at -78˚C. 
(4E,8E,12E)-8,12,17-trimethyloctadeca-4,8,12,16-tetraenal (0.4 g, 1.32 mmol) in THF (4 
mL) was then added and the reaction was allowed to warm to room temperature overnight.  
The reaction was quenched with a saturated solution of ammonium chloride and the layers 
were separated.  The aqueous layer was washed three times with diethyl ether and the 
combined organics washed with brine and dried over sodium sulfate.  Removal of solvent 
and purification by silica gel column chromatography (hexanes, Rf = 0.6) yielded the product 
(0.06 g, 0.2 mmol, 15% yield) 
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1
H NMR (600 MHz, CDCl3): δ 5.88-5.81 (m, 1H), 5.44 (m, 2H), 5.16-5.13 (m, 3H), 5.04 (dd, 
1H), 4.97 (dd, 1H), 2.11-2.04 (m, 16H), 1.72 (s, 3H), 1.62 (s, 9H) ppm.  
13
C NMR (152 
MHz, CDCl3): δ 138.5, 135.1, 134.6, 131.5, 130.5, 129.4, 124.5, 124.4, 124.3, 114.5, 39.75, 
39.74 33.9, 32.0, 31.2, 28.4, 28.3, 26.6, 25.7, 17.7, 16.01, 16.03 ppm.  HRMS (EI) C22H36 
[M]
+
/z calc. 301.2890 found 301.2892. 
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Cyclization Procedure 
(CNC)PtBr2 (0.005 mmol), dichloromethane (0.6 mL) and AgBF4 (0.0125 mmol) were added 
together and the mixture was stirred for 1 hour under N2 in the dark.  AgBr was then 
removed by syringe filter (0.45 µM PTFE) and substrate (0.033 mmol) was added to the 
solution.  Upon completion, the reaction was loaded directly onto a Ag
+
 impregnated silica 
gel
8
 column and eluted with hexanes to yield the desired product(s).  Fractions were analyzed 
by gc/ms. 
Cyclized products 5.6,5.8 and 5.9 were characterized based upon the previously reported
6
 
structure shown below.  We have previously assigned the 
1
H NMR shift of individual methyl 
groups of this fully methylated tetracycle.  Removal of specific methyl groups from the 
substrate yielded cyclised products lacking the previously assigned methyl signal in the 
1
H
 
NMR (ie the 5-demethylated substrate produced a tetracyclic product which lacked the 
methyl signal at 0.79 ppm). 
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5.9:  
1
H NMR (600 MHz, CDCl3): δ 2.17-2.13 (m, 2H), 1.95-1.87 (m, 2H), 1.83-1.58 (m, 
9H), 1.46-1.42 (m, 1H), 1.33-1.12 (m, 8H), 1.06-0.99 (m, 2H), 0.97 (s, 3H), 0.09 (s, 3H), 
0.85 (d, J = 7.2 Hz, 3H), 0.74 (d, J = 7.2 Hz, 3H) ppm.  
13
C NMR (152 MHz, CDCl3): δ 
143.2, 137.8, 52.6, 49.0, 44.6, 40.9, 37.0, 35.9, 34.5, 33.6, 30.6, 30.4, 29.9, 28.4, 27.0, 26.7, 
25.4, 22.8, 20.5, 18.5, 18.4, 17.8 ppm.  HRMS (EI) C22H36 [M]
+
/z calc. 301.2890 found 
301.2890. 
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5.6:  
1
H NMR (600 MHz, CDCl3): δ 2.23-2.17 (m, 1H), 2.09-2.01 (m, 2H), 1.98-1.94 (m, 
1H), 1.92-1.88 (m, 1H), 1.87-1.68 (m, 6H), 1.62-1.41 (m, 4H), 1.34-1.22 (m, 7H), 1.13-1.06 
(m, 2H), 0.98 (s, 3H), 0.86 (d, J = 6.6 Hz, 3H), 0.78 (s, 3H), 0.75 (d, J = 7.2 Hz, 3H) ppm.  
13
C NMR (152 MHz, CDCl3): δ 139.4, 137.2, 52.53, 52.47, 47.1, 38.3, 36.9, 36.2, 33.8, 21.7, 
30.8, 30.8, 29.5, 28.8, 26.9, 25.1, 23.2, 22.5, 22.1, 18.3, 17.6, 11.7 ppm.  HRMS (EI) C22H36 
[M]
+
/z calc. 301.2890 found 301.2892. 
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5.8:  
1
H NMR (600 MHz, CDCl3):  δ 2.46-2.44 (m,1H), 2.18-2.14 (m, 2H), 1.93-1.89 (m, 
2H), 1.87-1.81 (m, 1H), 1.76-1.65 (m, 6H), 1.55-1.38 (m, 4H), 1.27-1.21 (m, 6H), 1.15-1.03 
(m, 2H), 1.00 (s, 3H), 0.90 (d, J = 6.6 Hz, 3H), 0.79 (s, 3H), 0.69 (d, J = 7.2 Hz, 3H) ppm.  
13
C NMR (152 MHz, CDCl3): δ 146.0, 133.4, 55.3, 54.0, 48.6, 39.1, 38.1, 36.7 (x2), 29.0, 
28.7, 28.6, 26.9, 26.6, 26.2, 22.6, 21.6, 21.3, 20.5, 17.9, 16.0, 13.2 ppm.  HRMS (EI) C22H36 
[M]
+
/z calc. 301.2890 found 301.2893. 
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5.7:  
1
H NMR (600 MHz, CDCl3):  δ 2.73 (m, 1H), 2.57 (m, 1H), 2.22 (m, 2H), 1.77-1.60 (m, 
5H), 1.52-1.47 (m, 2H), 1.40-1.02 (m, 12H), 0.99 (d, J = 7.2 Hz, 3H), 0.97 (d, J = 7.2 Hz, 
3H), 0.87 (m, 1H), 0.76 (s, 3H), 0.68 (s, 3H) ppm.  
13
C NMR (152 MHz, CDCl3): δ 138.1, 
133.3, 62.8, 57.1, 48.5, 40.4, 39.7, 39.5, 36.9, 30.3, 28.8, 26.9, 26.5, 26.14, 26.06, 21.9, 21.7, 
21.3, 21.2, 20.9, 14.1, 13.1.  HRMS (EI) C22H36 [M]
+
/z calc. 301.2890 found 301.2894. 
 
Structural assignment of 5.7 was based upon the following NMR experiments.  The presence 
of only two sp
2 
carbons indicated the loss of four unsaturation equivalents and formation of a 
tetracyclic product.  The absence of vinylic protons indicated the formation of a 
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tetrasubstituted alkene.  Protons on methyl groups of C21 and C22 were identified by 
1
H 
NMR as the two doublets at 0.97 and 0.99 ppm.  From here, the isopropyl proton on C20 was 
identified as the downfield multiplet and confirmed by a selective 1D TOCSY experiment in 
which irradiation of this proton revealed revealed a correlation to the protons on C21 and 
C22 (blue arrow).  The absence of any other correlation in the 1D TOCSY experiment and 
the downfield shift of the proton on C20 indicated the positioning of the unsaturation.  The 
location of the remaining methyl groups C18 and C19 was confirmed by a 1D NOESY 
experiment which showed correlation between the two (red arrow). 
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APPENDIX A:  NEW CYCLIZATION INITIATORS 
Throughout this work, several new cyclization initiators were developed, producing 
new Pt-alkyl complexes.  Several different approaches to this task were explored.  The 
hard/soft acid-base theory has provided guidance in the search for complexes which may be 
easier to oxidize.  As discussed by Puddephatt,
1
 soft ligands, such as phosphines, prefer to 
bind to soft metals, such as Pt(II), whereas complexes with hard ligands, such as nitrogen 
donors, will better accommodate hard metals, such as Pt(IV).  With this in mind, Pt(terpy) 
was explored as a possible solution to the redox problems.  Cyclization of 1 equivalent of 6-
endophenol in the presence of 1 equivalent of piperidinomethyl polystyrene resin base 
resulted in formation of a new Pt-alkyl complex (Figure A.1).  While the complex proved 
sensitive to acid, isolation was possible, albeit in low yield. 
Figure A.1:  Cyclization by (terpy)Pt
2+ 
Reaction of the (terpy)Pt-R
+
 with several previously tested oxidants provided similar 
results to the (triphos)Pt-R
+
.  Reaction with CuCl2 provided a mixture of halogenated 
diastereomers and XeF2 provided the stereoretentive fluoride.  Attempts to enter a catalytic 
oxygenation scheme resulted in reactions that failed to consume starting material.  Reaction 
of the (terpy)Pt
2+
 with substrate in the presence of base provided the Pt-alkyl complex, 
however, in the absence of base, some cycloisomerization of substrate was observed, 
although the complex was limited to several turnovers.   
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The use of P3PPt
2+
 was briefly explored in the hope that the addition of a pendant 
phosphine may promote formation of a higher valent Pt-alkyl, making oxidation more facile.  
Reaction of P3PPt
2+
 with substrate in the presence of the resin base resulted in clean 
formation of a Pt-alkyl species similar to the (triphos)Pt-R
+
.  However, upon activation of 
P3PPtI2 with AgBF4, one equivalent of Ag was trapped by the pendant phosphine and carried 
through the cyclization, resulting in P(Ag)P3Pt-R as identified by 
31
P NMR (Figure A.2).  
Attempts to oxidize this complex resulted in complex mixtures of product, likely due in part 
to the presence of Ag in solution. 
 
Figure A.2:  Cyclization by P3PPt
2+ 
 Finally, the combination of a diphosphine and an NHC, previously reported by 
Marinetti
2
 in cycloisomerization reactions was used in the cyclization.  The combination of 
chiraphos and a simple NHC ligand formed a Pt-organometallic complex which proved 
stable to column chromatography (Figure A.3).  Although limited to a dr of 1.2.1, the chiral 
disphosphine ligand allowed for some diastereoselectivity in the reaction.  Despite the 
addition of the more electron donating NHC ligand, these complexes proved equally stable as 
the (triphos)Pt-R
+
 complexes toward oxidation.  This observation could potentially be 
explained by the removal of torsional strain in the complex relative to the triphos derivative.  
Additional torsional strain has been shown to help promote oxidation of Pt(II) complexes to 
Pt(IV) in previous protodemetallation chemistry.
3
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Figure A.3:  Cyclization by P2CPt
2+ 
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APPENDIX B:  ADDITIONAL SUBSTRATES 
 Several new substrates with varying methylation patterns were also synthesized.  
Initial tests on the viability of secondary carbocations in the cycloisomerization chemistry 
were performed with a tricylization reaction.  The synthesis of this substrate was shorter and 
provided a simpler means to perform a test reaction.  Cylization of this complex with the 
(CNC)Pt
2+
 catalyst formed two different products with initial reactions suggesting a solvent 
effect on product distribution.  In DCM, a single product was observed and characterized as 
the product resulting from a hyride shift and elimination, a structure confirmed by a 1D 
TOCSY experiment.  In nitromethane, a second product was formed roughly a 1:1 ratio, 
while this product was not fully characterized, crude NMR analysis suggested it was the 
product resulting from two hyride shift and elimination to form the B/C unsaturated product 
(Figure B.1). 
 
 
Figure B.1:  Tricyclization of secondary alkene containing substrate 
 A substrate with an additional methyl group, in the form of a tetrasubstituted alkee 
was also synthesized as a 1:1 mixture of E and Z isomers.  Cyclization of this substrate 
resulted in isolation of single product, while NMR suggested a structure consistent with that 
shown below, full characterization was not undertaken (Figure B.2).  Stereochemical 
assignment of this compound was not made due to the mixture of isomers of starting material 
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which could potentially lead to cis or trans ring junctions as predicted by the Stork 
Eschenmoser postulate. 
 
Figure B.2:  Cyclization of tetrasubstituted alkene containing substrate 
Experimental Section 
 
 
(5E,9E)-5,14-dimethylpentadeca-1,5,9,13-tetraene:  Triphenylphosphonium bromide (0.366 
g, 1.02 mmol) was dissolved in 6 mL of THF and cooled to -78˚C, n-BuLi (0.39 mL, 2.5 M 
in THF) was the added and the reaction was stirred for 1 hour.  (4E,8E)-4,13-
dimethyltetradeca-4,8,12-trienal was then dissolved in 4 mL THF and slowly added.  The 
reaction was allowed to warm overnight and quenched with saturated ammonium chloride 
solution.  The layers were separated and the aqueous was extracted three times with diethyl 
ether.  The combined organics were washed with brine and dried over sodium sulfate.  
Removal of solvent and purification by column chromatography (hexanes, Rf = 0.5) yield a 
colourless oil (0.11 g, 0.47 mmol, 56% yield). 
1
H NMR (600 MHz, CDCl3):  δ 5.84-5.81 (m, 1H), 5.45 (m, 2H), 5.17-5.14 (m, 2H), 5.05-
5.01 (m, 1H), 4.97-4.95 (m, 1H), 2.18-2.03 (m, 12H), 1.71 (s, 3H), 1.63 (s, 6H) ppm.  
13
C 
NMR (152 MHz, CDCl3): δ 138.8, 134.6, 131.5, 130.2, 130.2, 124.4, 124.2, 114.2, 39.1, 
32.9, 32.8, 32.4, 28.2, 28.1, 25.7, 17.8, 16.0 ppm. 
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1
H, 
13
C and 1D TOCSY were recorded in CDCl3.  The structure was determined to be 
tricyclic by the presence of only two sp
2
 carbon centres in the 
13
C NMR while the absence of 
vinyl peaks indicated a tetrasubstituted alkene.  The location of the tetrasubstituted alkene 
was confirmed by 1D TOCSY experiment in which the isopropyl methyl groups were 
irradiated and correlated only to a single proton. 
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1D TOCSY 
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